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7SCOPE OF THIS THESIS 
Accurate expression of our genes is facilitated by the tight regulation of RNA Polymerase 
II (Pol II) mediated transcription and by maintaining the integrity of the DNA template. 
DNA lesions that are located in the transcribed strand of genes may impede or completely 
block Pol II transcription. Such transcription-blocking DNA lesions (TBLs) cause DNA-
damaged-induced transcription stress, which may result in reduced cell function or cell 
death. To counteract these serious effects, most TBLs are resolved by transcription-coupled 
nucleotide excision repair (TC-NER). TC-NER is a highly conserved multi-step DNA-repair 
pathway that is initiated when elongating RNA polymerase II stalls on a TBL. While 
most key proteins involved in this versatile pathway have been extensively studied since 
the discovery of the pathway three decades ago, several aspects regarding the spatio-
temporal coordination of Pol II regulation and the adaptation of transcription to stressed 
conditions are not yet fully understood. These aspects are thoroughly reviewed and 
discussed in chapter 1. For example, while the physical block of elongating Pol II on 
DNA lesions (in cis) has long been acknowledged as the main cause for reduced Pol II 
transcription rates upon UV irradiation, recently accumulating evidence suggests that 
the signal-transduced regulation of Pol II throughout the nucleus (in trans) is an additional 
means to remotely control transcription in response to genotoxic stress. 
To study putative effects of transcription stress on Pol II in trans, it is crucial that 
TBLs are limited to a relatively small number of genes. Therefore we developed a highly 
sensitive method that allows monitoring Pol II behavior in living cells after the induction of 
very low damage loads. In chapter 2 we describe the CRISPR/Cas9-mediated generation 
of GFP-RPB1 (RPB1 is the largest subunit of Pol II) knock-in cells and their application as 
a live-cell imaging tool to determine the in vivo kinetics of endogenous Pol II. In contrast to 
the methods usually applied to study Pol II behavior, such as ChIP- or run-on-sequencing, 
this approach allows direct, real time assessment of Pol II dynamics without the use of 
transcription inhibitors or fixatives. Combined with computational modeling this approach 
allowed to kinetically dissect promoter-paused Pol II from initiating and elongating Pol 
II and showed that initiation and promoter proximal pausing are surprisingly dynamic 
events due to premature termination of Pol II promoter-binding. Our study provides new 
insights into Pol II dynamics and suggests that the iterative release and re-initiation of 
promoter-bound Pol II is an important component of transcriptional regulation.
In chapter 3, we demonstrate the powerful application of GFP-RPB1 KI cells to study 
the DNA-damage-induced transcription stress response in living cells after induction 
of physiologically relevant UV-induced damage loads. Monitoring the in vivo 
dynamics of Pol II in real time after low dose UV irradiation allowed us to decipher the 
VCP-mediated proteasomal degradation of promoter-paused Pol II as a new 
mechanism to regulate transcription in response to UV-induced TBLs. We showed 
that this mechanism is independent of TC-NER and the processing of lesion-stalled 
Pol II, and our data showed that it is regulated in trans. These findings suggest that 
the promoter proximal pause 
8of Pol II is not only a regulatory hub during unperturbed transcription, but is also 
an important target site to control transcription during damage-induced transcription 
stress. 
A powerful way to screen for new factors involved in a cellular process of 
interest is provided by the recently developed CRISPR/Cas9 technology in which 
pooled sgRNA libraries are used in combination with sequencing to identify genes that 
result in a growth advantage or disadvantage under selective pressure. In chapter 4 
we describe how we used this unbiased approach to acquire a comprehensive overview 
of factors involved in the UV-induced DNA damage response (DDR). We irradiated cells 
daily for 10 consecutive days with a low UV dose, applying a continuous selective 
pressure aimed at identifying factors that might have a function in the UV-DDR. This 
uncovered several new factors with potential roles in controlling cell survival as well 
as cell death after UV irradiation. Importantly, the validity of the screen is illustrated 
by the identification of genes with established functions in the UV-DDR as significant 
hits.
Investigating the - possibly subtle - role of newly identified factors in their 
contribution to DNA repair efficiency is challenging, as the currently available assays to 
quantify UV-induced DNA damage and repair are confined to endpoint 
measurements, are often limited by antibody specificity, and cannot be performed in 
living cells or at the single cell level. To circumvent these challenges, in chapter 5, we 
describe the generation of fluorescently-tagged UV lesion-specific photolyases (PLs) as a 
highly sensitive new tool to monitor DNA repair kinetics in living cells. CPD-PLs and 
6-4PP-PLs efficiently recognize and specifically bind to the respective photo lesion, 
allowing direct, real-time quantitation of UV-induced DNA damage in vivo. 
Furthermore, we showed that, using the 405 nm laser during live cell imaging 
experiments, PLs can be enzymatically activated to specifically photo-reactivate CPDs 
or 64PP lesions. This not only facilitates studying the behavior of repair factors upon 
instantaneous DNA repair in living cells, but also enables investigating whether 6-4PP 
and CPD lesions might trigger distinct cellular responses.
In Chapter 6 the main findings of this thesis and their implications on our 
current understanding of the cellular responses triggered by UV-induced DNA 
damage are highlighted and discussed. Finally, we propose several future research 
directions that may help to expand our insights into the DNA damage-induced 
transcription stress response. 
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ABSTRACT
The faithful transcription of eukaryotic genes by RNA polymerase II (Pol II) is crucial for 
proper cell function and tissue homeostasis. However, transcription-blocking DNA lesions 
of both endogenous and environmental origin continuously challenge the progression of 
elongating Pol II. The stalling of Pol II on a transcription-blocking lesion triggers a series 
of highly regulated events, including Pol II processing to make the lesion accessible for 
DNA repair, R-loop-mediated DNA damage signaling, and the initiation of transcription-
coupled DNA repair. The correct execution and coordination of these processes is vital 
for resuming transcription following the successful repair of transcription-blocking 
lesions. Here we outline recent insights into the molecular consequences of Pol II stalling 
on transcription-blocking DNA lesions and how these lesions are resolved to restore 
mRNA synthesis. 
INTRODUCTION
The accurate transcription of genes by RNA polymerase II (Pol II) is crucial for proper cell 
function and is therefore tightly regulated at each step of the Pol II transcription cycle 
(Box1) [1]. However, DNA damage continuously compromises the efficiency and fidelity 
of DNA transcription and threatens cell viability and genome integrity. Many different 
DNA damaging agents, of both endogenous and environmental origin, can cause DNA 
injuries that block or strongly hinder RNA polymerase II (Pol II) transcription elongation. 
Furthermore, in cycling cells, advancing replication forks can collide with stalled Pol II 
complexes [2]. The arrest of Pol II on transcription-blocking lesions (TBLs) leads to a lack 
of newly synthesized RNA molecules or may result in mutant mRNA. Not only these 
effects on RNA expression but also the prolonged arrest of Pol II itself are both highly 
cytotoxic. The stalling of Pol II on lesions for extended periods of time can arrest cell 
cycle progression and lead to apoptosis [3, 4]. If TBLs remain unrepaired, this blocked 
transcription can cause severe cellular dysfunction, eventually resulting in DNA-damage-
induced aging [5-7]. The structural complexity of lesion-stalled Pol II requires that an 
intricate protein network needs to be activated to ensure removal of genomic roadblocks 
and to overcome blocked transcription. The stalling of elongating Pol II on DNA lesions 
initiates transcription-coupled DNA repair (TC-NER), which is a multistep pathway that 
efficiently removes DNA lesions specifically from the transcribed strand of active genes. 
TC-NER is a sub-pathway of the multistep DNA repair pathway nucleotide excision repair 
(NER). NER can also be initiated via global genome NER (GG-NER), which recognizes helix-
destabilizing DNA lesions throughout the genome (Box 2) [8]. Only upon completion of 
TC-NER stalled transcription will restart [9]. The biological relevance of this DNA repair 
pathway is best demonstrated by the severe phenotypes of human disorders that are 
related to defective TC-NER [7, 9, 10]. However, even though the concept of TC-NER 
was discovered three decades ago [9, 11], many questions remain unanswered about 
how cells coordinate transcription arrest and TBL repair, and subsequently restart mRNA 
synthesis. Here, we discuss the multifaceted cellular response that is triggered following 
the stalling of Pol II on TBLs. 
Fates of lesion-stalled Pol II
To repair TBLs, TC-NER faces a significant steric problem: Pol II may be trapped near to 
or right on top of a TBL, severely obstructing the access of repair factors to the lesion 
[7, 9] (Fig. 1a). Different types of TBLs differentially inhibit the forward translocation 
of the transcription machinery [9, 12]. For example, UV-induced cyclobutane-pyrimidine 
dimers cause the arrest of Pol II on top of the TBL. The 35-nucleotide footprint of 
the stalled Pol II is asymmetrically located around the lesion, covering 10 nucleotides 
downstream and 25 nucleotides upstream of the UV-lesion [13-15]. By contrast, cisplatin-
induced inter-strand crosslinks stall Pol II before the lesion can enter the polymerase’s 
active site [16]. Oxidative DNA lesions such as 8-oxo-7,8-dihydroguanine (8-oxo-G), which 
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Box 1. Schematic illustration of the Pol II transcription cycle. Eukaryotic gene expression is 
a highly regulated process that is initiated by the sequential binding of general transcription
factors that facilitate the recruitment of RNA polymerase II (Pol II) (1). During initiation
the CDK7 subunit of the hetero-trimeric CAK sub-complex of transcription factor II H 
(TFIIH) phosphorylates the serine 5 (Ser5) of the heptapeptide repeat of the C-terminal 
domain (CTD) of RPB1, the core catalytic subunit of Pol II, allowing Pol II to start transcribing 
RNA (Scheidegger and Nechaev 2016). This early elongation complex is paused 30 to 60 
nucleotides downstream of the transcription start site (TSS) by Negative elongation factor
(NELF) and DRB sensitivity inducing factor (DSIF) and is referred to as ‘promoter proximal
pause’ (2). The subsequent pause release of Pol II into productive elongation is mediated by 
the CDK9 subunit of the positive transcription elongation factor b (P-TEFb). CDK9-mediated 
phosphorylation (▼) converts DSIF into a positive elongation factor, facilitates the eviction 
of NELF, and phosphorylates the RPB1 CTD on Ser2, allowing Pol II to escape the promoter 
and to begin productive elongation (Jonkers and Lis 2015). Early elongating Pol II is marked 
by P-Ser5 and P-Ser2, whereas Pol II elongating further downstream of the TSS are marked 
mostly by P-Ser2 (3). Once released from the promoter-proximal pause site, Pol II starts to 
productively elongate until it encounters a termination signal, at which the mature mRNA 
is cleaved and Pol II is dissociated from the chromatin template, for example by the action 
of the the 5’-3’ exoribonuclease XRN2, which co-transcriptinally degrades the 3’ end of 
Pol II-associated RNA and thereby promotes the dissociation of Pol II from chromatin in 
a torpedo-like manner (Proudfoot 2016) (4).
Eukaryotic gene expression is a highly regulated process that is initiated by the sequential binding of general transcription
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are induced by endogenous reactive oxygen species, also interfere with transcription. 
However, the damage-induced transcription stalling of Pol II does not appear to be caused 
by 8-oxo-G itself, but rather indirectly by base excision repair intermediates [17-19]. 
To overcome persistent Pol II stalling and to facilitate access of the DNA repair 
machinery, cells have evolved three different mechanisms to displace lesion-stalled Pol II: 
reverse translocation, degradation, and lesion bypass (Fig. 1b).
Reverse translocation, or backtracking, of Pol II not only occurs in the presence of 
TBLs, but also when Pol II encounters DNA sequences that are difficult to transcribe 
[20]. In bacteria, the DNA helicase UvrD travels along with elongating Pol II and 
moves the complex backwards upon encountering a DNA lesion [21]; and a similar 
backtracking mechanism has also been suggested for higher eukaryotes, though this 
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Figure 1 The arrest of elongating RNA polymerase II (POL II) on a transcription blocking DNA lesion (TBL)
triggers a series of cellular events
Figure 1. The arrest of elongating RNA polymerase II (POL II) on a transcription blocking DNA lesion 
(TBL) triggers a series of cellular events. (a) Elongating POL II runs into a TBL and stalls (b) R-loops 
can be formed by hybridisation of pre-mRNA with template ssDNA adjacent to the transcription 
bubble. TBL induced R-loop formation activates non-canonical ATM signaling, whch in turn results 
in eviction of co-transcriptional spliceosomes. (c) To allow access of the repair machinery to TBLs, 
the damage-stalled POL II has to be removed from the lesion. POL II processing might occur via TFIIS 
and Ccr4-Not mediated backtracking (top panel). Alternatively RPB1, the largest subunit of the POL 
II complex, might be ubiquitylated and proteasomally degraded. Segregase activity is needed to 
extract RPB1 from chromatin (middle panel). Lesion bypass of POL II might also make the lesion 
accessible, however this might result in mutant RNA (bottom panel). (d) Transcription Coupled 
DNA repair (TC-NER) is initiated when POL II stalls at a TBL during transcript elongation. Whether 
TC-NER stimulates backtracking or backtracking is needed to initiate TC-NER is unknown. During 
transcript elongation UV-stimulated scaffold protein A (UVSSA), ubiquitin-specific-processing 
protease 7 (USP7) and Cockayne syndrome protein B (CSB) transiently interact with POL II. Upon 
stalling at a TBL, the affinity of CSB for RNA Pol II increases, which recruits the WD40 protein CSA. 
CSA and CSB complex are required for the subsequent steps of the NER reaction (step1). After 
damage recognition, the TFIIH (transcription initiation factor IIH) complex is recruited to the lesion 
and the structure- specific endonuclease XPG binds to the pre-incision NER complex. The helicase 
activity of TFIIH further opens the double helix around the lesion. The TFIIH helicase subunit XPD 
unwinds the DNA 5’–3’ and verifies the existence of lesions with the help of the ATPase activity of 
the TFIIH subunit XPB subunit and XPA. XPA and RPA then recruit the endonuclease XPF–ERCC1, 
which creates an incision 5’ to the TBL. This results in the activation of XPG, which cuts the damaged 
strand 3’ to the lesion. This excises the lesion within a 22–30 nucleotide-long strand (step3). Gap 
filling synthesis by DNA Pol δ, DNA Pol κ or DNA Pol ε can begin immediately after the 5’ incision is
made. The NER reaction is completed through sealing the final nick by DNA ligase 1 or DNA ligase 
3 (step4). 
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Box 2. Global Genome NER (GG-NER). The main damage sensor in GG-NER is XPC. In 
complex with RAD23B and centrin 2 (Cen2) (Hoogstraten, Bergink et al. 2008), XPC 
constantly probes the DNA for helix-distorting lesions (Nishi, Okuda et al. 2005). Mildly helix 
distorting lesions such as CPDs, which are poor substrates for XPC, require the action of 
the UV-DDB2 complex, consisting of DDB1 and DDB2. The latter binds damaged base pairs, 
kinks the DNA backbone to extrude the lesion into its binding pocket and thereby facilitates 
XPC binding opposite to the DNA lesion (Sugasawa, Okamoto et al. 2001) (1). Lesion-
bound XPC subsequently recruits transcription factor II H to sites of DNA damage (TFIIH) 
(Riedl, Hanaoka et al. 2003). After damage recognition, GG-NER and TC-NER converge into 
a mutual pathway, collectively referred to as NER, which is described in Figure 1.
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has not yet been confirmed [8, 20-22]. To resume transcription after backtracking, 
the protruding nascent RNA needs to be cleaved to reposition the 3’ end of the RNA 
in the active site of the polymerase [23]. In eukaryotes, this reaction is mediated by 
transcription factor IIS (TFIIS), which stimulates the intrinsic 3’–5’ exonuclease activity of 
Pol II [13, 24-26]. A recent study showed that TFIIS recruitment to elongating Pol II is 
increased by the Ccr4-Not complex, and consequently the authors suggested that TFIIS 
and Ccr4-Not work together to reactivate arrested Pol II [27]. In addition, Ccr4-Not may 
promote the resumption of elongation by binding to the emerging transcript protruding 
from the polymerase [28]. 
Pol II backtracking upon collision with a TBL would provide the space needed for 
the TC-NER machinery to repair the TBL. This principle was elegantly demonstrated by 
researchers in the Hanawalt laboratory [13, 29], who showed that photolyases, which 
specifically bind UV-induced DNA lesions, could only recognize TBLs following the TFIIS-
mediated backtracking of arrested Pol II [29]. Furthermore, TFIIS was shown to be involved 
in the efficient recovery of transcription following UV irradiation, emphasizing its role in 
TC-NER [30]. While little is still known about factors that mediate Pol II backtracking, 
the process may be facilitated by sliding of the upstream nucleosomes by the histone 
acetyltransferase p300 and the nucleosome binding protein HMGN1, both of which 
interact with stalled Pol II [9, 31]. In addition, the key TC-NER protein Cockayne syndrome 
B (CSB) may be involved in the displacement of stalled Pol II, as it contains a SWItch/
sucrose non-fermentable (SWI/SNF2) ATPase domain and has chromatin remodeling 
activity that is stimulated by the histone chaperone NAP1 [32-34].
If backtracking fails, arrested Pol II may be degraded instead, most likely to prevent 
genomic roadblocks being caused by its persistent stalling. Ubiquitylation and degradation 
of RPB1, the largest and core catalytic subunit of Pol II, also occurs during basal 
transcription elongation [35, 36]; however, it is greatly increased following genotoxic 
stress [37, 38]. After a decade of discovering the individual factors that are involved 
in RPB1 degradation [39-42], Harremann and colleagues clarified the pathway in yeast 
by ordering the actions of distinct and sequentially acting ubiquitin ligases and de-
ubiquitylating enzymes (DUBs) [43]. 
In yeast, the HECT ubiquitin ligase Rsp5 binds to the C-terminal domain of RPB1 [39] 
and modifies the subunit with a K63-linked polyubiquitin chain, which by itself does not 
trigger proteolysis. This K63-polyubiquitin chain is then trimmed by the DUB Ubp2 [43]. 
The residual monoubiquitin on RPB1 can either be hydrolyzed by Ubp3, rescuing RPB1 
from degradation [44], or extended to K48-linked-polyubiqutin by the Elc1/Cul3 ligase 
complex, marking RPB1 for proteasomal degradation [43]. Finally, the ring-like AAA+ 
ATPase CDC48/p97 is required to segregate the K48-polyubiquitylated yeast Rpb1 from 
chromatin, and to facilitate RPB1 degradation by the 26s proteasome [45]. Remarkably, 
RPB1 is the only subunit of the 12-subunit Pol II complex that is degraded following UV 
exposure [46, 47].
It is currently unknown whether the DNA damage-induced degradation of Pol II by 
the successive action of different ubiquitin ligases is conserved in mammals. The mammalian 
RSP5 homolog Nedd4 was found to ubiquitylate RPB1 in human cells, resulting in its 
degradation upon genotoxic stress [48]. However, Nedd4-depleted cells are not sensitive 
to UV light [48], indicating that it is not the only factor required to modify RPB1 upon UV 
exposure. It has also been shown that the von Hippel-Lindau tumor suppressor protein 
(pVHL) can bind RPB1 in a proline-hydroxylation-dependent manner and functions as an 
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E3 ligase that targets elongating RPB1 for ubiquitylation and degradation in response to 
UV light. pVHL negative cells were shown to accumulate elongating RPB1 and undergo 
apoptosis in response to UV, whereas cells expressing pVHL were less apoptotic [49]. 
These results clearly indicate that pVHL plays a role in eukaryotic RPB1 degradation. pVHL 
is a crucial component of the VHL-E3 ubiquitin ligase complex, which consists of Elongin 
BC, Cullin2, and Rbx1. In this complex, pVHL serves as substrate recognition unit and 
the Cullin/Rbx module functions as a ubiquitin-activating enzyme [50]. The mammalian 
ElonginA-ElonginBC-Cul5/Rbx2 complex can also efficiently ubiquitylate RPB1 in 
vitro [51]. However, rather than pVHL induced degradation of elongating RPB1 (Ser2-
phosphorylated), Elongin A and Cul5 interact with initiating RPB1 (Ser5-phosphorylated) 
upon exposure to UV light. Furthermore, Ser5-phosphorylated RPB1 has also been shown 
to be a substrate for the BRCA1/BARD1 ligase complex [52]. Interestingly, BRCA1 also 
ubiquitylates the Pol II subunit RPB8 in response to UV irradiation, but this ubiquitylation 
does not result in RPB8 degradation [53].
The observation that initiating Ser5-phosphorylated RPB1 is targeted by specific E3 
ligases raises the exciting possibility that the collision of Pol II with TBLs in the gene body 
may also have consequences for transcription-initiating Pol II complexes at the promoter. 
Since the regulation of transcription is far more complex in eukaryotes than in yeast, 
including, for example, promoter-proximal pausing [54-56], it is tempting to speculate 
that Pol II stalling initiates a much more sophisticated cellular response in mammalian 
cells compared with yeast. In support of this speculation, it was recently shown that UV 
irradiation results in the loss of Pol II at the promoters of many transcribed genes [57], 
suggesting a genome-wide mechanism that regulates transcription initiation in response 
to TBLs. 
It is unclear whether the valosin-containing protein VCP/p97, which is the human 
homologue of the yeast ATPase CDC48/p97, is required for chromatin extraction of 
mammalian RPB1. Even though several key players in the ubiquitylation of mammalian 
RPB1 have been identified, our understanding of RPB1 degradation in mammals is 
incomplete. The identification of many distinct ligases that are involved in the degradation 
of mammalian RPB1 highlights the importance of Pol II regulation by ubiquitin, but further 
research is needed to fully understand the precise interplay of all of the factors involved.
Finally, DNA lesions that are encountered by Pol II may be bypassed, although this 
occurs infrequently [9, 58]. If the helix distortion of a TBL is minimal, such as at a-basic 
sites or single-strand breaks, it might translocate into the Pol II active site. The subsequent 
translocation is disfavored, but not totally blocked [58]. Lesion bypass can be stimulated 
by various transcription factors, such as CSB [59] or TFIIF [60], but this is at the cost 
of transcriptional mutagenesis [61]. Nucleotide mis-incorporation due to lesion bypass 
can have serious consequences for the cell if the faulty nucleotide leads to changes in 
the amino acid coding and the expression of mutant proteins. 
Which type of Pol II processing ultimately occurs upon Pol II stalling at a TBL 
(backtracking, degradation, or bypass) and how these options are regulated in the cell 
remains largely unknown. The pathway choice is probably influenced by the nature of 
the TBL and the chromatin environment, but may also be affected by cell type, cell cycle 
stage, or gene-specific regulation of transcription. 
TBL arrest of Pol II induces R-loops, spliceosome eviction, and 
non-canonical ATM signaling
The association of multi-megadalton spliceosomes with nascent RNA may pose another 
steric challenge to the repair of TBLs. It was recently reported that late-stage spliceosomes, 
composed of U2, U5, and U6 small nuclear ribonucleoproteins (snRNPs) are rapidly 
excluded from DNA damage sites in response to UV-induced TBLs [62]. This displacement 
of co-transcriptional spliceosomes from arrested Pol II most likely results in an increase in 
R-loop formation through the hybridization of pre-mRNA with template ssDNA adjacent
to the transcription bubble [62, 63] (Fig. 1b). Persistent R-loops are genotoxic, as they
can interfere with transcription and replication, increase the probability of replication
fork collapse following collisions with stalled transcription complexes, and promote
unscheduled replication by transcription-associated recombination. Furthermore,
the ssDNA in the R-loop poses a further threat to genome fidelity, as it is sensitive
to mutagens, can undergo spontaneous hydrolysis, and is prone to the formation of
secondary structures such as G-quadruplexes. To counteract R-loop toxicity, cells are
equipped with specialized RNA hydrolases (RNaseH1 and H2) or helicases (e.g., Pif1,
DHX9, and senataxin) that unwind the RNA:DNA hybrid [64-67]. In the context of
TBLs, R-loop formation leads to non-canonical activation of the ataxia-telangiectasia
mutated (ATM) protein kinase, which signals the further mobilization of spliceosomes
from elongating polymerases, as well as those that are located distal to Pol II-blocking
DNA lesions. The exact molecular mechanism by which TBLs activate ATM remains
unclear [62, 63]. Interestingly, ATM, via R-loop formation, relays the local (cis) event of Pol
II arrest to the genome-wide (trans) modulation of alternative splicing, adapting global
gene expression, and shaping the proteome in response to TBLs [62, 68].
Initiation of transcription-coupled repair (TC-NER)
To counteract the fatal implications of lesion-stalled Pol II, TC-NER has evolved to 
specifically remove a wide range of helix-distorting lesions that impede the elongation of 
Pol II from actively transcribed genes. TC-NER is initiated by the recruitment of Cockayne 
syndrome A and B (CSA, CSB) [8, 9], and the UV-stimulated scaffold protein A (UVSSA) 
[69-71] to lesion-stalled Pol II (Fig. 1d). CSB has ATPase-dependent chromatin remodeling 
activity and may locally modify the DNA conformation [32, 33, 72]. CSB recruits CSA, 
which is part of a Cullin-RING ubiquitin E3 ligase complex, that was described to target 
CSB for ubiquitylation and degradation [73]. CSB degradation is counteracted by UVSSA, 
which recruits the de-ubiquitylating enzyme USP7 and thereby stabilizes CSB at the site 
of damage [69, 71]. Although CSA is dispensable for the attraction of the excision repair 
INTRODUCTION
20 21
11
machinery, in combination with CSB it is essential for the recruitment of xeroderma 
pigmentosum group A (XPA)-binding protein 2 (XAB2), a pre-mRNA splicing factor that 
is involved in TC-NER [73-75]. Following damage detection, the transcription factor II 
H (TFIIH) complex unwinds a stretch of approximately 30 nucleotides surrounding 
the damage site. XPA then stimulate the damage-verification activity of TFIIH. XPA and 
replication protein A (RPA) orient the XPF/excision repair cross-complementing 1 (ERCC1) 
and XPG endonucleases, which subsequently excise the damaged DNA. The resulting gap 
is filled by DNA synthesis and sealed by DNA ligases [76, 77]. In addition to NER, another 
mechanism to remove UV-induced DNA lesions exists, namely the light-activated catalytic 
reversion of CPD and 6-4PP lesions by photolyases (Box 3). However, this mechanism was 
lost in eukaryotes during evolution.
Restarting transcription upon repair of TBLs
Although the successful repair of a TBL is necessary, this in itself is not sufficient for 
transcription restart following genotoxic stress, which is essential for cell survival. Several 
factors that have explicit roles in TC-NER-associated transcription restart, but not in repair 
itself, have been identified over the past few years. For instance, the eleven-nineteen 
lysine rich leukemia (ELL) protein, which interacts with TFIIH via the Cdk7 subunit of 
the CDK-activating kinase (CAK) complex, was found to be essential for transcription 
resumption following the removal of TBLs, and yet was not involved in the repair of 
TBLs [78]. Moreover, downregulation of ELL increased Pol II chromatin retention in a UV-
dependent manner. Together, these findings suggest that ELL serves as a docking site for 
proteins involved in the regulation of Pol II-mediated transcription restart once repair has 
been completed [78].
The chromatin environment (i.e., histone chaperones, histone variants, and post-
translational modifications of histones) also plays an important role during the restart of 
transcription following DNA damage. For example, knockdown of the histone chaperone 
HIRA impairs the recovery of RNA synthesis following UV damage to an extent that is 
comparable to that seen in TC-NER-deficient cells, but does not affect the recruitment of 
repair factors. HIRA accumulates at sites of DNA damage, where it deposits the histone 
variant H3.3, which is crucial for facilitating transcription recovery upon the repair of TBLs 
[79]. In addition, H2A/H2B dimer exchange has also been found to increase at sites of 
UV-induced DNA damage [80]. This damage-induced histone exchange is mediated by 
the histone chaperone facilitates chromatin transcription (FACT). FACT is a heterodimer 
consisting of the SPT16 and SSRP1 subunits, and is a known H2A/H2B chaperone [81]. 
Although both FACT subunits are recruited to sites of UV damage, only SPT16 depletion 
results in a loss of damage-induced H2A/H2B exchange. Spt16 is required for the efficient 
restart of RNA synthesis following UV damage. This suggests that the FACT subunit 
SPT16 plays a specific role in damage-induced chromatin dynamics and transcription 
recovery [80]. In addition, knockdown of the methyltransferase disruptor of telomeric 
silencing 1-like (DOT1L) results in UV-sensitivity, whereas DNA damage is removed 
Box 3. Catalytic cycle of photolyase-mediated photo-reactivation of pyrimidine dimers (T=T). 
UV light leads to the formation of pyrimide dimers in the DNA, such as cyclobutane pyrimidine 
dimers (CPDs) and pyrimidine-pyrimidone photoproducts (6-4PPs) (1). While NER is the only 
mechanism to repair these DNA lesion in placental mammals, the photo-reactivation (PR) 
of pyrimidine dimers by damage specific photolyases (PL) is an alternative damage removal 
mechanism present in  bacteria, fungi, plants and some non-placental mammals (Thompson 
and Sancar 2002). In contrast to the complex multi-protein NER mechanism (see Box 2), 
PR by PLs is the direct reversal of CPDs and 6-4PPs by one single enzyme, CPD-photolyase 
(CPD-PL), and 6-4PP-photolyase (6-4PP-PL), respectively. PLs recognize the distinct helix 
distortions created by photo dimers and bind to them through ionic interactions (Sancar 
2008) (2). While the binding of PL to the DNA lesion is independent of light, the catalytic 
reversal of pyrimidine dimers to the original bases, i.e. their photo reactivation, requires 
the absorption of a photon with a wavelength between 300 and 500nm (3). Catalysis 
by PL encompasses the energy transfer from the blue light photon to the flavin cofactor 
(FADH-) of the PL, and the electron transfer from FADH- to the cyclobutane ring, which splits 
the pyrimidine dimer and forms a flavin radical (FADH-). The catalytic cycle is completed 
when the electron is transferred back to the cofactor, restoring catalytically active, fully 
reduced FADH- (Huang, Baxter et al. 2006)(Wang, Saxena et al. 2005)(Kao, Saxena et al. 
2005) (Sancar 2008) (4). The entire reaction takes ~1 ns for both types of PLs after which 
the PLs are released (Sancar 2008) (5).
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Box 3 Catalytic cycle of photolyase‐mediated photo‐reactivation of pyrimidine dimers (T=T)
normally [82]. Thus, the activities of HIRA, FACT, and DOT1L are thought to generate 
the proper chromatin environment or provide the correct chromatin plasticity needed 
for efficient transcription recovery following the removal of TBLs [83]. Interestingly, 
transcription restart following treatment with the transcription inhibitor 5,6-dichloro-
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1-beta-D-ribofuranosylbenzimidazole (DRB) occurs independently of DOT1L and HIRA
[79, 82]. This indicates that transcriptional restart following DNA damage removal and
basal transcription initiation are distinctly regulated. Together, these findings highlight
that repair of the transcribed strand alone is not sufficient for the cell to restore mRNA
expression. Transcription restart requires the synergy of many factors, including not
only the discussed chromatin remodellers, but most likely also additional transcriptional
regulators [83, 84].
Activating transcription factor 3 (ATF3) is one example of a transcriptional regulator 
that is involved in transcription restart upon DNA damage but not repair [85]. ATF3 
expression is dramatically upregulated by various stress signals, including UV damage. 
The binding of ATF3 to its target genes usually silences them [86]. However, although 
the transcription of ATF3 target genes recovers 12–24 h following UV damage in TC-
NER-proficient cells, the ATF3 target gene repression is prolonged in CSB-deficient cells, 
likely due to ATF3 impeding Pol II access to the promoter. Supporting this, silencing 
ATF3 rescues the transcription restart defect in CSB-deficient cells. These findings allocate 
a new role to CSB besides its key function in sensing lesion-arrest of Pol II: CSB may also 
be involved in overcoming the silencing of ATF3-dependent genes. Furthermore, these 
results imply that there is a direct link between the stalling of Pol II in the gene body and 
the inhibition of transcription that is regulated via the promoter [85]. 
This raises an interesting question: does the restart of Pol II transcription upon TBL 
only occur locally at the site of damage, or does it also occur genome-wide at non-
arrested polymerases? (See Fig. 2.) Although the suggested TFIIS and Ccr4-Not mediated 
backtracking of Pol II would allow to resume elongation of the same transcript, there 
is currently no experimental proof for this mechanism. Interestingly, recent genome-
wide analyses of nascent RNA-Seq data suggest that transcription recovers in a wave 
from the 5’-end of genes upon TBL induction by either UV irradiation or treatment with 
the topoisomerase 1 inhibitor camptothecin [87-89]. A wave-like recovery of transcription 
following genotoxic stress would implicate two interesting new concepts: (1) a significant 
part of transcription restarts at the beginning of genes, rather than at the sites where 
Pol II initially stalled; and (2) transcription does not restart stochastically upon repair of 
individual genes, but rather simultaneously, in a regulated manner in most genes [12].
Perspective
Over the past few decades, we have acquired an impressive body of knowledge about 
the cellular response to transcription-blocking DNA damage. However, to further improve 
our understanding of the post-repair transcription restart process, several questions 
remain to be answered. 
Pol II processing upon DNA damage has been thoroughly studied, with Pol II 
displacement by backtracking, degradation, or lesion bypass now being widely accepted 
mechanisms. However, what guides this choice of pathways remains largely known. 
The degradation of arrested Pol II is assumed to be a last resort mechanism that occurs 
only when lesion-stalled Pol II cannot be resolved, as occurs, for example, in the absence 
of TC-NER proteins [90]. However, although preserving Pol II and its transcript from 
degradation by means of Pol II backtracking intuitively seems to be the most favorable 
scenario, experimental evidence to support such regulation is scarce. It is possible that 
Pol II degradation is favored over backtracking above a certain threshold of damage. 
Alternatively, the pathway choice to process stalled Pol II may be guided by the complexity 
of the lesion or the chromatin environment, or may even be gene specific.
A better insight into the fate of lesion-stalled Pol II may also improve our understanding 
of TC-NER-associated phenotypes. TC-NER defects in humans cause Cockayne syndrome 
(CS) or UV sensitivity syndrome (UVsS). CS and UVsS cells are equally deficient in TC-NER 
in vitro, and yet the patients exhibit strikingly distinct clinical symptoms: CS patients 
display severe developmental, neurological, and premature aging features, whereas 
UVsS individuals present with a much milder phenotype that is mostly restricted to UV 
hypersensitivity [9, 10, 91]. How molecular defects within the same pathway can lead 
to such strikingly diverse phenotypes remains unresolved, but may be associated with 
the specific functions of the CS proteins outside TC-NER [92, 93], such as transcription 
‘cis’ ‘trans’
arrest
restart
general transcription factors
bound to promotor
transcribing Pol II arrested Pol II
TSS
Restart at lesion
Pol II
TBL
repair
Restart at promotor
Figure 2 Potential mechanism of transcription arrest and restart in ‘cis’ or ‘trans’ upon stalling of RNA Polymerase
2 (POL II) on a transcription blocking lesion (TBL)
Figure 2. Potential mechanism of transcription arrest and restart in ‘cis’ or ‘trans’ upon stalling of 
RNA Polymerase 2 (POL II) on a transcription blocking lesion (TBL). A regulation in ‘cis’ implies that 
only those POL II that hit a TBL will stall and cause transcription inhibition (indicated by ˧). Other 
POL II transcribing the same or other genes are not affected and keep transcribing (indicated by →). 
Upon repair of TBLs arrested POL II might resume transcription at the site of stalling (right panel). 
A regulation in ‘trans’ would arrest also other polymerases on the damaged gene, maybe including 
both initiating and elongating POL II. ‘Trans’ regulation might even include arrest of POL II on other 
undamaged genes (not shown). Restart of transcription upon TBL repair may occur at the site of 
arrest (not shown), but also by re-initiation of POL II at the promoter. If the latter scenario happens 
in a regulated manner at many promoters, transcription would recovery as a wave from the 5’ start 
of genes (left panel).
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initiation [94], the maintenance of mitochondrial DNA stability [95, 96], or the regulation 
of specific transcriptional programs [97]. Another hypothesis suggests that aberrant 
processing of lesion-stalled Pol II may explain the differences between the UVsS and CS 
phenotypes. Here, it is proposed that in CS cells, which lack functional CSB, Pol II cannot 
be degraded or displaced [9], and so the lack of TC-NER combined with the persistent 
arrest of Pol II leads to apoptosis and senescence, causing the severe CS phenotype. By 
contrast, in UVsS cells, which lack functional UVSSA, stalled Pol II may still be ubiquitylated 
or displaced in a CSA/CSB-dependent manner, making the lesion accessible for alternative 
DNA repair mechanisms, including global genome NER or base excision repair, and thus 
resulting in the milder UVsS phenotype [8, 98]. 
To date, no study has investigated whether damage-induced R-loop formation and 
non-canonical ATM activation contribute to the phenotypes of these TC-NER syndromes. 
It has been reported that CSB is required to resolve R-loops, whereas XPC (the protein 
that initiates global genome NER) is not. However, CSB-mediated R-loop removal results 
in DNA breaks [66]. CSB may not only promote R-loop removal by excision [66], but 
also by resolving lesion-stalled Pol II, which is an important source of R-loops [66, 
99]. Furthermore, R-loop-induced spliceosome displacement may promote TBL repair 
by facilitating Pol II backtracking or removal [62, 68]. Alternatively, the loss of the co-
transcriptional splicing machinery may be linked to a regulated inhibition of transcription 
via non-canonical ATM signaling. However, the role of R-loop-induced ATM activation as 
a new mechanism of transcription-stress signaling requires further investigation.
TBLs may have strikingly different outcomes in different organs and cell types [8, 
100-103]. A clear example of this is the extreme damage sensitivity of photoreceptor cells
in the retina of TC-NER-deficient mice and the neurodegeneration in CS patients [100,
104, 105]. This suggests that DNA damage induction, recognition, repair, and signaling
also differ between tissues and cell types, which would result in respective changes in
the level of damage-induced mutagenesis, senescence or cell death. Several factors may
influence the differential cellular consequences to TBL exposure, including transcription
levels, chromatin states, or differential activity of the DNA-repair pathways [106].
Finally, differences in replication rates may also lead to strong differences in the cellular
consequences of TBLs. In contrast to post-mitotic differentiated cells, in replicating cells
advancing replication forks may collide with TBL-stalled Pol II complexes, which can have
severe cellular outcomes [64, 107]. However, comprehensive studies on tissue-specific
regulation of lesion-stalled Pol II and its underlying mechanisms are currently lacking.
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ABSTRACT
Initiation and promoter-proximal pausing are key regulatory steps of RNA Polymerase 
II (Pol II) transcription. To study the in vivo dynamics of endogenous Pol II during these 
step we generated fully functional GFP-RPB1 knock-in cells. GFP-RPB1 photo-bleaching 
combined with computational modeling revealed 4 kinetically distinct Pol II fractions and 
showed that on average 7% of Pol II are freely diffusing, while 10% are chromatin-bound 
for 2.4 s during initiation, and 23% are promoter-paused for only 42 s. This unexpectedly 
high turnover of Pol II at promoters is most likely caused by premature termination of 
initiating and promoter-paused Pol II, and is in sharp contrast to the 23 min that elongating 
Pol II resides on chromatin. Our live-cell imaging approach provides new insights into Pol 
II dynamics and suggests that the continuous release and re-initiation of promoter-bound 
Pol II is an important component of transcriptional regulation. 
SIGNIFICANCE STATEMENT
Transcription by RNA Polymerase II (Pol II) is a highly dynamic process that is tightly 
regulated at each step of the transcription cycle. We generated GFP-RPB1 knock-in cells 
and developed photo-bleaching of endogenous Pol II combined with computational 
modeling to study the in vivo dynamics of Pol II in real time. This approach allowed 
to dissect promoter paused Pol II from initiating and elongating Pol II and showed 
that initiation and promoter proximal pausing are surprisingly dynamic events due to 
premature termination of Pol II. Our study provides new insights into Pol II dynamics 
and suggests that the iterative release and re-initiation of promoter-bound Pol II is an 
important component of transcriptional regulation.
INTRODUCTION
Eukaryotic gene expression is a highly regulated process initiated by the sequential 
binding of transcription factors that facilitate the recruitment of RNA polymerase II 
(Pol II) and the assembly of the preinitiation complex (PIC) [1]. During initiation the CDK7 
subunit of TFIIH phosphorylates serine (Ser) 5 of the C-terminal domain (CTD) of RPB1, 
the core catalytic subunit of Pol II, allowing Pol II to engage the DNA template and to start 
transcribing a short stretch of RNA [2, 3]. This early elongation complex is paused 30 to 
60 nucleotides downstream of the transcription start site by Negative elongation factor 
(NELF) and DRB sensitivity inducing factor (DSIF) [4, 5]. The subsequent pause release 
into productive elongation is mediated by the positive transcription elongation factor 
b (P-TEFb), whose Cdk9 kinase converts DSIF into a positive elongation factor, facilitates 
the eviction of NELF, and phosphorylates the RPB1 CTD on Ser2 [2].
Traditionally it was thought that transcription is primarily regulated by Pol II recruitment 
and initiation, but owing to the advances in genome-wide sequencing technologies 
we know today that mRNA output is also controlled by the tight coordination of post-
initiation steps [2, 5]. For example, promoter proximal pausing is a key rate-limiting 
step of RNA synthesis that serves as a checkpoint for 5’ capping of the nascent RNA 
and maintains an open chromatin structure near promoters [6]. Originally discovered as 
a regulatory switch of stimulus responsive genes in Drosophila [7], recent genome-wide 
studies have revealed that promoter pausing is a widespread phenomenon occurring 
on most metazoan genes [5, 8]. Yet, despite this prevalence the dynamics of promoter-
paused Pol II remain under debate. The currently prevailing model suggests that Pol II 
pauses at promoters with a half-life of 5-15 minutes [8-12], serving as an integrative hub 
to control pause release into productive elongation, while promoter proximal termination 
is infrequent. However, conflicting studies have reported that promoter-paused Pol II 
is less stable due to repeated premature termination and chromatin release proximal 
to the promoter, which is accompanied by the release of short transcription start site-
associated RNAs RNAs [13-16].
Thus far, genome-wide dynamics of promoter-paused Pol II have been studied by 
Gro-seq [8], ChIP-Seq [10, 11] or methyltransferase footprinting [15] after inhibiting Pol II 
initiation. While these techniques provide gene-specific snapshots of Pol II transcription, 
relative abundance, or position at a given time, they do not allow to measure steady 
state Pol II kinetics, i.e. chromatin binding times, in real time. Though these studies have 
gained insights into the turnover of paused Pol II, most experiments have been performed 
after inhibiting transcription initiation by Triptolide[8, 10-12]. This covalent XPB inhibitor 
severely affects Pol II levels [17, 18] and has been recently shown to have a slow mode 
of action [16], which makes it less suitable to study a potentially rapid cellular process. 
To overcome these limitations we developed photo-bleaching of endogenously expressed 
GFP-RPB1 followed by computational modeling to quantitatively assess the kinetics of Pol 
II in unperturbed living cells. 
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Here we show that GFP-RPB1 knock in (KI) cells generated by CRISPR/Cas9-mediated 
gene targeting are fully functional and provide a promising new tool to study the steady-
state kinetics of endogenous Pol II. By photo-bleaching of GFP-RPB1 we identified 
three kinetically distinct fractions of chromatin-bound Pol II. Using Monte Carlo-based-
based modeling of Pol II kinetics we assessed the quantitative framework of the Pol II 
transcription cycle and elucidated its timeframe and quantitative set-up. Our findings are 
highly supportive of a model in which Pol II initiation and promoter pausing are highly 
dynamic events of iterative cycles of Pol II chromatin binding and release. 
RESULTS
Generation and characterization of GFP-RPB1 cells
To study the in vivo kinetics of endogenous Pol II we generated a GFP-RPB1 (POLR2A) 
knock-in (KI) cell line (MRC-5 sv40) fluorescently labeling the largest subunit of Pol II. We 
transiently expressed a single guide RNA (sgRNA) to induce a CRISPR-associated protein 
9 (Cas9)-mediated double strand break (DSB) downstream of the RPB1 transcriptional 
start site. A repair template containing GFP cDNA flanked by homology arms comprised 
of the genomic RPB1 sequence [19] (Fig S1a) was co-transfected to allow repair of the DSB 
by homologous recombination. GFP positive cells were isolated by FACS and single-cell 
clones of homozygous knock-in (KI) cells were selected (Fig S1b) in which wild type (WT) 
RPB1 was replaced by GFP-RPB1, as shown by western blot (Fig 1a) and genotyping 
(Fig S1c). Importantly, the GFP-RPB1 expression level and phosphorylation status in KI cells 
were similar to WT cells (Fig 1a), the GFP tag did not compromise the basal transcription 
rate (Fig 1b, S1d), and did not alter gene expression profiles (Fig S1e). Live-cell confocal 
imaging of KI cells revealed a non-homogenous, nuclear distribution of GFP-RPB1 with 
multiple bright foci and exclusion from nucleoli (Fig 1c). Localization of GFP-RPB1 was 
similar to endogenous RPB1, shown by immunofluorescent stainings of the RPB1 CTD 
and NTD (Fig 1d). Together these data illustrate that GFP-RPB1 is fully functional. 
As GFP-RPB1 is expressed from its endogenous gene loci and RPB1 only translocates 
to the nucleus as part of the fully assembled Pol II complex [20], nuclear GFP fluorescence 
can be used as a direct readout for endogenous Pol II localization and concentration in 
living cells. To estimate the number of Pol II complexes, we compared the nuclear GFP 
intensity of KI cells to the extracellular fluorescence of known, increasing concentrations of 
recombinant fluorescent GFP added to the culture medium (Fig 1e). This direct comparison 
of fluorescence on the same microscope slide revealed a nuclear Pol II concentration of 
0.18 µM. Based on the determined average nuclear volume of the KI cells of 734µm3 this 
equals ~50,000 Pol II per diploid genome (Fig 1e), which is within the range of previously 
determined Pol II quantities [21].
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Figure 1 Characterization of GFP-RPB1 knock-in cells
Figure 1. Characterization of GFP-RPB1 knock-in cells. Western blot of MRC-5 wild type (WT) 
and GFP-RPB1 knock in (KI) cells. NTD= N-terminal domain, CTD= C-terminal domain, Pol IIA = 
hypo-phosphorylated Pol II, Pol IIO= hyper-phosphorylated Pol II, P-Ser = phosphoserine. EU 
incorporation levels of WT and KI cells. Mean total nuclear fluorescence intensity (FI) ± SD, n= 60 
cells, 2 independent experiments. Live-cell images of KI cells. Arrows indicate foci of locally enriched 
Pol II. Immunofluorescent stainings of RPB1-CTD (left) and RPB1-NTD (right) in WT and KI cells. DNA 
is stained with DAPI, GFP fluorescence from endogenously expressed GFP-RPB1. Representative 
images of KI cells with increasing concentrations of free GFP in the culture medium. Extracellular 
GFP fluorescence was plotted against GFP concentration to make a standard curve (graph, bottom 
left) and nuclear Pol II concentration was calculated based on the standard curve (indicated with 
the green arrow). Numbers used to calculate the amount of Pol II in a diploid nucleus are summarized 
in the table (bottom right). Table shows mean ± SD, n= 40 cells of 2 independent experiments.
Initiation, promoter pausing, and productive elongation are 
characterized by distinct Pol II kinetics
This multitude of Pol II complexes is divided over the different stages of the transcription 
cycle, including initiation, promoter pausing, and productive elongation. Previous 
studies have indicated that Pol II mobility is linked to its state of engagement during 
transcription [22-24], however, thus far promoter-proximally paused Pol II could not be 
discriminated and quantified in living cells. To test whether this fraction could be identified 
LIVE-CELL ANALYSIS OF ENDOGENOUS GFP-RPB1 
36 37
22
in GFP-RPB1 KI cells expressing Pol II at endogenous levels, we determined the kinetic 
framework of the Pol II transcription cycle by fluorescence recovery after photo-bleaching 
(FRAP) [25, 26].
First, we measured the redistribution of Pol II after photo-bleaching in half the nucleus 
(Fig 2a). Half-nucleus FRAP revealed an initial, fast redistribution of Pol II followed by a slow 
recovery of apparently less mobile Pol II. In line with previous studies [22-24] we assumed 
that the latter fraction represents long-term chromatin-bound, elongating Pol II that are 
released from chromatin over time when transcription terminates. Pol II fluorescence was 
fully recovered 80 min after the bleach pulse, likely reflecting the engagement of a small 
fraction of Pol II with very long or slowly transcribed genes. (Fig 2a)
For a more detailed analysis of Pol II kinetics we performed FRAP in a narrow strip 
spanning the nucleus (Strip-FRAP) [26], allowing fluorescence measurements every 0.4 
seconds. In line with half-nucleus FRAP, Strip-FRAP of GFP-RPB1 in non-treated cells 
(NT) showed a long-term immobilization of a large fraction of Pol II (Fig 2b), hereafter 
referred to as long-bound fraction (Fig 2b, for clarification approximated with green 
dotted line). To investigate the nature of this long-bound fraction we measured Pol 
II mobility after treatment for 1hr with 100μM Cordycepin, a 3’-deoxy nucleoside 
that inhibits transcript elongation when incorporated into RNA [27] (Fig 2d). Indeed, 
Cordycepin reduced EU incorporation (Fig S2a, S2b) without affecting Pol II protein levels, 
determined by quantifying GFP fluorescence either prior to FRAP (Fig 2c right panel), by 
immunofluorescence (Fig S2b bottom panel), or western blot (Fig 2e). The chromatin 
release of specifically the long-bound fraction was markedly decreased after Cordycepin 
(Fig 2c), indicating that the long-bound fraction mainly represents elongating Pol II. 
Cordycepin-mediated inhibition of elongation also markedly delayed the redistribution 
of Pol II after half-nucleus FRAP (Fig S2c), corroborating that the long-bound fraction 
mainly reflects the behaviour of productively elongating Pol II. This allocation was 
further validated by the depletion of the transcription factor IIS (TFIIS) (Fig 2g, S2d). 
TFIIS stimulates the intrinsic cleavage activity of Pol II needed to reactivate complexes 
that have been arrested during productive elongation [28]. Similar as after Cordycepin 
(Fig 2c), simultaneous siRNA-mediated knockdown of the TFIIS paralogues TCEA1 and 
TCEA2 (Fig2f, S2d) decreased the chromatin release of long-bound Pol II (Fig2g).
In addition to the large fraction of elongating Pol II with long-term chromatin binding, 
Strip-FRAP revealed a fraction of short-term chromatin-bound Pol II and a fraction with 
intermediate chromatin binding, hereafter referred to as the short-bound and the medium-
bound fractions (Fig 2b, approximated with grey and purple dotted lines, respectively). To 
investigate the nature of these fractions we performed Strip-FRAP using inhibitors that 
specifically arrest Pol II at defined, consecutive stages of the transcription cycle (Fig 2d). 
THZ1 inhibits CDK7 [29], the TFIIH subunit that phosphorylates Ser5 of the RPB1 
CTD and thereby prevents promoter pausing, mRNA capping and subsequently Pol II 
transition into productive elongation [30]. As expected, treatment with 1 μM of THZ1 for 
90’ resulted in a loss of hyper-phosphorylated Pol II (Pol IIo), P-Ser2 (Fig 2e) and loss of EU 
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Figure 2 Real-time measurements of Pol II kinetics at different transcription cycle stages
Figure 2. Real-time measurements of Pol II kinetics at different transcription cycle stages. 
Fluorescence recovery after photo-bleaching (FRAP) of the bleached and fluorescence loss in photo-
bleaching (FLIP) of the non-bleached half of nuclei are plotted in time. Images are snapshots of 
a representative cell at indicated time points. RFI=Relative fluorescence intensity, Mean of n=20 cells 
of 2 independent experiments. Strip-FRAP analysis of GFP-RPB1 in non-treated (NT) cells. GFP-RPB1 
was bleached in a narrow strip spanning the nucleus. Fluorescence recovery was measured 
every 0.4s for 4min, background corrected and normalized to pre-bleach fluorescence intensity. 
The dotted lines indicate kinetically distinct Pol II fractions, which mainly represent Pol II complexes 
that are short-term (grey), medium-term (purple), or long-term (green). Mean ± SD, n=20 cells 
of 2 independent experiments.Strip-FRAP of GFP-RPB1 in NT cells and after 1h of treatment with 
the indicated transcription inhibitors. Column chart on the right shows average GFP-RPB1 pre-bleach 
fluorescence intensities (FI) of cells analysed by FRAP as a measure for Pol II protein levels. n>16 
cells per condition measured in 2 independent experiments. FI chart shows mean ± SD. Schematic 
representation of Pol II transcription cycle and points of action of the used transcription inhibitors. 
THZ1 inhibits the phosphorylation of Ser5 by Cdk7. Flavopiridol inhibits the phosphorylation of 
Ser2 by Cdk9. Cordycepin is a 3’deoxy adenosine analogue that stalls chain elongation when 
incorporated into the mRNA. Actinomycin D is a DNA intercalator. Pol II= RNA Polymerase II, CTD= 
C-terminal domain, P-Ser= phosphoserine. c Western blot of GFP-RPB1 KI whole cell lysates (WCL)
and chromatin and nucleoplasm fractions of non-treated (NT) cells and cells treated for 90min with
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incorporation (Fig S2a, S2b top panel), indicating a run-off of most engaged, elongating 
Pol II, without affecting Pol II protein levels (Fig 2c right panel, S2a, S2b bottom panel) 
or the cell cycle (Fig S2e). In addition to the loss of promoter-paused Pol II [30], THZ1-
treated cells showed a loss of phosphorylated Ser5 (P-Ser5) (Fig 2e) and reduced Pol 
II promoter-binding (Fig 2f). Accordingly, FRAP after THZ1 showed a decreased slope 
of the curve compared to NT cells at time points >100 seconds (Fig 2c, yellow line), 
i.e. a loss of elongating Pol II. In addition, THZ1 extensively enlarged the short-bound 
fraction of Pol II, indicating that Pol II is not stably chromatin-bound. This was confirmed 
by the increased detection of non-phosphorylated Pol II ( Pol IIo) in the nucleoplasm after 
cellular fractionation (Fig 2e), concomitant with a loss of Pol II in the pellet fraction. As Pol 
II can still be incorporated into the PIC in the absence of CDK7 activity [30], this indicated 
that the short-bound fraction mainly represents free and initiating Pol II. Remarkably, 
the very fast replacement of bleached Pol II by new and fluorescent Pol II in THZ1-treated 
cells suggests that initiation is a highly dynamic process of continuous cycles of Pol II 
release and re-binding of new Pol II. In addition to the increase of short-bound Pol II, THZ1 
treatment resulted in the loss of both the long and the medium-bound Pol II fractions 
(Fig 2c). As THZ1 prevents both Pol II promoter pausing and productive elongation 
(Fig 2d,f and S2a,b) [30], and we assigned the long-bound fraction to productively 
elongating Pol II, we hypothesized that the medium-bound fraction might represent 
promoter-paused Pol II.
To test this we inhibited the transition of Pol II from pausing to productive elongation 
with the CDK9 inhibitor Flavopiridol. The CDK9 activity of the PTEF-b complex licenses Pol 
II pause release by phosphorylating DSIF, NELF, and Ser2 of the RPB1 CTD [2, 8, 31, 32]. 
As expected, inhibition of Pol II pause release by incubation with 1µM Flavopiridol for 
90 min increased Pol II promoter binding (Fig2f), and inhibited productive elongation 
(Fig 2e, Fig S2a, S2b top panel) [8, 31, 32]. Similar to THZ1, Flavopiridol markedly enlarged 
the fraction of short-bound Pol II (Fig 2c) and resulted in a loss of productively elongating 
Pol II, as shown by the horizontal slope of the slow fraction at time points >100 seconds. 
Most importantly and in striking contrast to THZ1, the medium-bound fraction of Pol II 
remained after Flavopiridol (Fig 2c yellow versus red curve), strongly suggesting that Pol 
II with intermediate kinetics represent mostly promoter-paused Pol II. Similar results were 
obtained with another CDK9 inhibitor, DRB. Intriguingly, the fluorescence recovery after 
photo-bleaching in Flavopiridol-treated cells was complete after ~100sec (Fig 2c), which 
implied that within this short time frame all Pol II that were paused during the bleach 
pulse were already replaced by new, fluorescent Pol II. This FP-induced accumulation 
the indicated transcription inhibitors. NTD= N-terminal domain of RPB1. Pol II binding to the RPLP1 
promoter measured by chromatin-IP. Wild type (WT) and cells expressing free GFP (GFP) were 
analysed as controls (ctrl). Mean ±SEM of n=3 independent experiments. FRAP of GFP-RPB1 after 
transfection with a non-targeting control siRNA (siCTRL) or siRNAs targeting the TFIIS paralogues 
TCEA1 and TCEA2 (siTFIIS). Mean of n=20 cells of 2 independent experiments
of a fraction of Pol II that is only transiently chromatin-bound was corroborated by an 
accumulation of P-Ser5 positive Pol II in the nucleoplasm after cellular fractionation (Fig 
2e). Together these results suggested that Pol II promoter pausing is surprisingly dynamic 
and presumably consists of iterative rounds of pause entry and promoter-proximal 
termination, i.e. release from chromatin and not release into productive elongation. 
Importantly, the expression of non-coding genomic loci such as enhancer RNAs and 
upstream antisense RNAs, which would results in short Pol II chromatin binding times, has 
been shown to be dependent on CDK9 activity [33-35] and hence we conclude that their 
contribution to the medium-bound fraction, which is not reduced but rather increased 
after Flavopiridol (Fig 2c,f), is limited. 
Treatment with 1 μg/ml of Actinomycin D, a DNA intercalator [36], for 90 min , 
completely inhibited transcription (Fig S2a, and S2b top panel). In line with the loss of 
nucleoplasmic Pol II after Actinomycin D (Fig 2e) both the short and the medium-bound 
fractions were completely lost (Fig 2c). Most Pol II remained chromatin-bound after 
Actinomycin D resembling the Pol II FRAP curve in PFA-fixed cells, suggesting that after 
Actinomycin D most Pol II are stably trapped on DNA. 
Computational Model of steady state Pol II kinetics
By inhibiting specific transitions in the Pol II transcription cycle we demonstrated that Pol 
II engaged in initiating, promoter pausing, and productive elongation are characterized 
by significantly distinct kinetics. While the use of transcription inhibitors allowed to assign 
kinetically distinct Pol II fractions to specific stages of the transcription cycle, we cannot 
exclude possible additional effects of these inhibitors on Pol II dynamics and stability. For 
example, it has recently been shown that Cdk9 inhibition by Flavopiridol also affects Pol 
II initiation [11]. It is therefore important to extract information about Pol II kinetics from 
unperturbed cells. To do so, we used Monte Carlo (MC) modeling to computationally 
simulate Pol II kinetics and fitted the simulated curves to the Pol II Strip-FRAP curves. MC 
modeling is based on the assumption that (molecular) events have a certain probability 
to occur within a specific short period of time (in a living cell) [37]. As every transcription 
cycle starts with Pol II binding to the promoter we defined one single binding step upon 
initiation (Fig 3a). Supported by our analysis with specific transcription inhibitors (Fig 2c) 
we proposed, in addition to freely diffusing Pol II, three interconnected Pol II fractions 
with three possible exit points: Pol II release after initiation, after promoter pausing, and 
after transcription termination [13-15, 24, 38] (Fig 3a). The best simulations obtained 
from this model fit the experimental FRAP curves very well (Fig S3a-i). From the average of 
the ten best fitted MC simulations (Fig S3j-m) we extracted quantitative information about 
the relative size of the kinetically distinct Pol II fractions, their respective residence times 
on chromatin, and their binding constants (kon and koff). This approach favored a model 
in which 60% of all nuclear Pol II are productively elongating with a residence time on 
chromatin for ~23 min on average (Fig 3b, 3c right panel). These results were in line with 
the large fraction of long-term chromatin-bound Pol II observed during FRAP experiments 
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Figure 3 Monte Carlo Modeling of live cell Pol II kinetics
Figure 3. Monte Carlo Modeling of live cell Pol II kinetics. Schematic representation of possible 
binding and release steps of Pol II to DNA. Modeled fraction sizes are depicted as percentages 
and written in italics. Modeled residence times of Pol II in different stages are written in bold. 
Chances for Pol II to pass through or exit a stage were calculated from kon and koff rate constants 
(see methods) and are given as percentages. * marks points of abortive Pol II release, ∆ marks Pol 
II release after transcription termination.  Fraction sizes and Residence times of short, medium, and 
long-bound Pol II fractions obtained from Monte Carlo-based modeling of GFP-RPB1 FRAP data (Fig 
2b) of non-treated (NT) GFP-RPB1 knock in cells or after 1hr of treatment with 1µM THZ1, or 1µM 
Flavopiridol, or 100µMCordycepin. Mean ±SD of the 10 best fitting simulations. 
(Fig 2a,b). When combined with the number and length of expressed genes, these 
results allowed to deduce the average Pol II elongation speed in unperturbed conditions. 
Therefore we determined the number and average length of all actively transcribed genes 
in immortalized human fibroblasts using existing nascent RNA-Seq data [39] (Dataset 
S1). We included all genes with >0.2 reads per kb of transcript per million mapped reads 
(RPKM) and a gene length >300 bp in the analysis, which resulted in ~13.600 actively 
transcribed genes with an average, expression frequency-corrected gene length of 46 
kb (see Dataset S1, sheet 2). Together, these numbers resulted in an average elongation 
speed of 2 kb/min in living cells (Dataset S1, sheet3), which is in line with previously 
reported Pol II elongation speeds determined by run-on sequencing [8, 40]. 
Promoter-bound Pol II are rapidly turned over
MC modeling of RPB1 kinetics further allowed to extract relative fraction sizes and 
revealed that ~10% of Pol II are involved in initiation (short-bound fraction) and ~23% 
are promoter-bound during promoter pausing (medium-bound fraction). This implied 
that most Pol II (93%) are chromatin-bound and that only 7% are freely diffusing in 
the nucleus (Fig 3b, 3c). In line with the fast recovery of photo-bleached Pol II after 
THZ1 (<10 seconds) and Flavopiridol (<100 seconds), MC modeling of Pol II kinetics in 
unperturbed cells revealed that initiating Pol II remains chromatin-bound for only 2.4 
seconds (Fig 3c left panel) and promoter-paused Pol II for merely 42 seconds. Interestingly, 
these big differences in the residence time of initiating (2.4 sec), promoter pausing (42 
sec) and elongating (23min) Pol II implied that only a small fraction of initiating and 
pausing Pol II can proceed to the subsequent step of the transcription cycle, and hence 
that most initiating and pausing Pol II must be released from chromatin at the promoter 
(Fig 3a-c). In line, analysis of the rate constants of the distinct Pol II fractions showed that 
only 1 out 8 Pol II that attempt initiation will proceed to promoter pausing, and that only 
1 out of 13 promoter-paused Pol II will continue to productive elongation (Fig 3a). When 
combined, this implied that only 1 out of 100 transcription initiation events finally results 
in mRNA production. 
Of note, the average of three independently modeled FRAP experiments resulted in 
highly similar estimates of fraction sizes and residence times and illustrates the variation 
between biological experiments (Fig S4a). Furthermore, the modeled parameters were 
hardly affected by adding artificial noise to FRAP curves (Fig S4b), further validating our 
MC-based modeling approach.
Modeling of Pol II kinetics after transcription inhibition
One of the current models of Pol II promoter pausing suggests that the release of promoter-
paused Pol II occurs mainly by transition to productive elongation [5]. Our results however, 
indicated a very rapid turnover of promoter-paused Pol II, which most likely cannot not 
be explained solely by release of promoter-paused Pol II into productive elongation. 
Therefore we tested whether Cdk9-mediated pause release influences the half-life of 
promoter-paused Pol II by determining the residence time of paused Pol II after blocking 
pause release with FP. Interestingly, MC-based modeling indicated that Flavopiridol did not 
increase the residence-time of promoter-paused Pol II, (Fig 3c middle panel), illustrating 
that Pol II turnover at the promoter is hardly affected by Pol II release into productive 
elongation, and suggesting that the half-life of paused Pol II is mainly determined by 
promoter-proximal termination. Although Flavopiridol is known to accumulate paused 
Pol II at promoters by inhibiting the transition to productive elongation [8, 16, 41], it 
only resulted in a 35% increase of the fraction size of paused Pol II (Fig 3b), which is 
comparable to observed increases in Pol II promoter occupancy [8] (Fig S2e). The increase 
of paused Pol II was concomitant with a decrease of initiating Pol II and is in line with 
the recent finding that paused Pol II inhibits Pol II initiation [11]. 
Modeling of Pol II kinetics after THZ1 or Flavopiridol revealed a substantial increase 
in freely diffusing Pol II, whereas the fraction of initiating Pol II was slightly reduced 
(Fig 3b), suggesting that Pol II initiation frequency does not directly depend on the number 
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of freely diffusing Pol II. The very small fraction of elongating Pol II that remained after 
THZ1 and Flavopiridol resided longer on the gene body (Fig 3c, right panel) and might 
represent a sub-fraction of Pol II that did not run off within the 90 min of inhibitor 
treatment, likely because they transcribe very long genes or genes with a low elongation 
speed. Interestingly, Cordycepin increased the fraction size of elongating Pol II (Fig2f), 
and reduced the number of free Pol II (Fig2f). In addition to the shift of fraction sizes, 
Cordycepin increased the residence time of elongating Pol II three-fold (Fig 3f right panel), 
arguing for a strongly decreased elongation speed after treatment with this elongation 
inhibitor, without affecting transcription initiation. MC-modeled fraction sizes of Pol II 
were well in line with Pol II quantities detected in the chromatin-bound or nucleoplasmic 
fraction following cell fractionation, in both non-treated conditions or after treatment 
with different transcription inhibitors (Fig S4c).
Kinetics of Pol II after treatment with Triptolide or α-Amanitin
We demonstrated, that GFP-RPB1 KI cells are a suitable tool to quantitatively assess real 
time Pol II transcription kinetics and Pol II concentration. Next we applied this tool to 
study the effects of Triptolide and α-Amanitin, 2 widely used compounds that inhibit
Pol II transcription and induce Pol II degradation. Triptolide inhibits the ATPase activity of 
the TFIIH subunit XPB, thereby preventing the opening of the transcription bubble, which 
consequently blocks transcription and triggers Pol II degradation [18, 42, 43] (Fig 4a right 
panel, S5a). Cells that were treated with 0.5 μM Triptolide for 90min showed a sharp 
increase of the short-bound Pol II fraction and a loss of both the medium and long-bound 
Pol II fractions (Fig 4a, 4b), similar to what we observed after THZ1 (Fig 2c). The residence 
time of short-bound Pol II after Triptolide or THZ1 was similar to NT conditions (Fig S5d), 
indicating that the turnover of initiating Pol II binding is barely affected by its transition 
to promoter pausing. In contrast to THZ1, 90 min of Triptolide resulted in a loss of ~50% 
of Pol II compared to non-treated cells as determined by live-cell imaging (Fig 4a right 
panel). Triptolide-induced Pol II degradation could be rescued by proteasome inhibition 
(Mg132, 50µM for 1hr before Triptolide), which further increased the short-bound Pol II 
fraction (Fig 4a), most likely due to accumulation of free Pol II (Fig 4b). This indicates that 
the fraction of Pol II that is targeted for degradation after Triptolide is highly mobile. Of 
note, Mg132 alone did not affect Pol II mobility or protein levels (Fig S5b). Interestingly, 
rescue of Triptolide-induced Pol II degradation by Mg132 accumulated P-Ser5 Pol II, 
suggesting that CDK7 can phosphorylate CTD Ser5 independently of transcription 
bubble opening and that this Ser5-phosphorylation might be a prerequisite for Pol II 
degradation after Triptolide. To test this hypothesis, we inhibited the Triptolide-induced 
Ser5-phosphorylation with THZ1 (Fig S5c). The addition of THZ1 completely rescued 
the Triptolide-induced Pol II degradation (Fig 3a right panel), in line with a model in 
which in the absence of an open transcription bubble due to Triptolide, P-Ser5 Pol II fails 
to escape the PIC and is subsequently degraded. 
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Figure 4 Live-cell Pol II kinetics after Triptolide and α-Amanitin
Figure 4. Live-cell Pol II kinetics after Triptolide and α-Amanitin. FRAP of GFP-RPB1 in non-treated
(NT) cells and cells treated with 0.5µM Triptolide for 1h (a) or 100µg/ml α-Amanitin for 2h (c).
Mg132=proteasome inhibitor. Mean of n=20 cells of 2 independent experiments, FI chart shows 
mean ± SD. Modeled, FI-corrected Pol II fraction sizes in NT KI cells or after treatment with Triptolide 
(b) or α-Amanitin (d). Mean ±SD of the 10 best fitting simulations.
Another widely used transcription inhibitor is α-Amanitin. α-Amanitin traps Pol II in
a conformation that prevents translocation of the transcript and thereby inhibits nucleotide 
incorporation [42]. Thus far the effect of α-Amanitin on Pol II in living cells could not
be extensively studied as most studies using fluorescently tagged Pol II were performed 
using an exogenously expressed α-Amanitin-resistant Pol II mutant [24, 44, 45]. FRAP of
GFP-RPB1 after treatment with 100 μg/ml α-Amanitin for 90 min showed a loss of free,
short-bound and medium-bound Pol II, whereas the long-bound, elongating fraction 
did not change in size (Fig 4d), but increased in residence time (Fig S5e), illustrating 
the reduced productive elongation rate after α-Amanitin [46]. In addition, α-Amanitin led
to degradation of Pol II (Fig 4c right panel, Fig S5a). Interestingly, rescue of α-Amanitin-
induced Pol II degradation by Mg132 tremendously increased the free fraction of Pol 
II (Fig 4d), as shown by an increase of the short-bound fraction during FRAP (Fig 4c), 
suggesting that stalled and presumably ubiquitylated Pol II is evicted from chromatin 
before proteasomal degradation.
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DISCUSSION
Detailed knowledge of the dynamics of Pol II transcription is crucial to understand 
the complex regulation of Pol II transcription. To study the in vivo dynamics of 
endogenously expressed Pol II we generated GFP-RPB1 KI cells and used them to monitor 
real time Pol II kinetics. Photo-bleaching experiments revealed three kinetically distinct 
fractions of Pol II that remained chromatin-bound for either 2.4, 42, or 1370 seconds 
(Fig 3c). Using dedicated inhibitors that block transcription at specific stages we allocated 
these fractions to Pol II engaged in initiation, promoter pausing, or productive elongation 
(Fig 2b). Allocation of these fractions allowed to model Pol II kinetics and to construct 
a kinetic framework of steady-state Pol II transcription in unperturbed conditions. 
FRAP allows the discrimination of promoter-paused Pol II based on its 
distinct kinetics
Interestingly, a previous study on the in vivo kinetics of YFP-tagged α-Amanitin-resistant
Pol II on a lacO array integrated into U2OS cells also identified three different Pol II 
populations with chromatin binding times of 6, 54, and 517 sec, respectively [24]. 
The authors linked the fastest Pol II fraction to Pol II transiently interacting with promoters, 
while the slowest fraction was allocated to elongating Pol II. However, the fraction with 
intermediate kinetics was linked to initiating Pol II. Although the residence time of their 
intermediate fraction was strikingly similar to ours (54 s vs. 42 s), which would suggest 
that this might represent the same population of Pol II, their fraction was insensitive 
to P-TEFb inhibition, while we observed an increase in the fraction sizes of initiating 
and promoter-paused Pol II (Fig 3b). Hence, for the first time, our study discerned 
the kinetic fraction of Pol II that corresponds to promoter-paused complexes. While 
THZ1 and Triptolide abrogate promoter pausing and productive elongation, Flavopiridol 
still allows Pol II initiation and pausing but inhibits the release of Pol II from pausing to 
productive elongation. In line, we observed that in Flavopiridol-treated cells, the short 
and the medium-bound Pol II fractions remained, while the long-bound fraction was lost, 
strongly suggesting that the medium-bound fraction mainly represents promoter-paused 
Pol II. Of note, Flavopiridol accumulated transcription-competent but promoter-paused 
Pol II, as tested by performing FRAP after washing out Flavopiridol after 60 minutes of 
treatment, which resulted in Pol II kinetics similar to non-treated cells within minutes.
Pol II promoter pausing is a highly dynamic event
The average of the ten best fitting, simulated chromatin binding times of promoter-
paused Pol II was 42 seconds in unperturbed conditions. Although we cannot exclude 
that Pol II is stably paused with residence times longer than 100 sec on some specific 
loci, as for example shown by tracking photoactivatable Pol II at the uninduced Hsp70 
transgene of Drosophila polytene chromosomes [9], we found that on a genome wide 
average 23% of nuclear Pol II is paused for merely 42 seconds in human cells(Fig 2b, 
Fig 2c middle panel). While this result differs strikingly from previous studies that found 
Pol II to be stably paused at promoters with half-lives of 5-15 minutes [8-12], it is in line 
with the very fast (<100sec) fluorescence recovery of Pol II in Flavopiridol-treated cells (Fig 
2c). To our best knowledge the most likely explanation for this discrepancy may be that 
these previous studies were performed in the presence of Triptolide [8, 10-12], which 
disturbs transcriptional regulation and Pol II stability [17, 18 ],(Fig S5a). Furthermore, 
Triptolide may not be fully functional instantly upon administration and it is therefore 
difficult to exactly time the Pol2 half-life at promoters [15, 16]. Stable pausing of Pol 
II on promoters also has been challenged recently by DNA foot printing experiments in 
Drosophila cells, that have revealed that most promoter-paused Pol II is lost within 2.5 
min (the earliest time point assessed by the authors) after Triptolide [15]. Rapid promoter-
proximal termination was also found to be the most plausible explanation for the drastic 
increase of promoter-paused Pol II within a minute after H2O2 administration to U2OS 
cells [16]. In agreement with their conclusions, our findings strongly support a non-
processive model of transcriptional idling of promoter-paused Pol II, defined by iterative 
rounds of Pol II pause entry and promoter-proximal termination [13-16]. As blocking 
the transition to productive elongation with Flavopiridol did not increase the residence-
time of promoter-paused Pol II (Fig 3c middle panel), we further suggest that the Pol II 
turnover at the promoter is independent of its release into productive elongation but 
is mainly a result of continuous premature termination [15]. Importantly, our findings 
additionally elucidate the timeframe and the quantitative set up of these processes. In 
light of the increasing evidence supporting the dynamic turnover of promoter-bound Pol 
II, it is very tempting to speculate that the release of Pol II into productive elongation 
might be, at least partially, regulated by inhibiting promoter proximal Pol II termination.
Not only promoter-paused, but also initiating Pol II complexes are 
rapidly turned over
In addition to termination of Pol II after promoter pausing, our results further suggested 
that Pol II is frequently released from chromatin after initiation (Fig 3a). This abortive 
release after 2.4 seconds occurred even when the transition from initiation to pausing 
was blocked by THZ1 (Fig 3c) or Triptolide (Fig S5d), implying that the turnover of initiating 
Pol II does not depend on its transition to promoter pausing. The very fast recovery of 
fluorescence after photo-bleaching of initiating Pol II after THZ1 and Triptolide (Fig 2c) 
additionally implied that the Pol II that is abortively released after initiation (which is 
bleached during FRAP) is not the same complex that re-initiates (which is fluorescent 
and causes the fast fluorescence recovery). Similar observations have been made for 
the TATA-box binding protein [47, 48], further corroborating a model in which Pol II 
PICs are rapidly assembled and disassembled, rendering initiation highly dynamic. 
However, it has also been reported that a subset of the transcription machinery remains 
at the promoter after transcription initiation, forming a reinitiation scaffold that facilitates 
high levels of transcription inititation [49]. 
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Implications of dynamic Pol II turnover at promoters
As a consequence of the frequent abortive release after initiation and pausing, according 
to our model, only one mRNA transcript will be synthesized per 100 Pol II initiation 
events on average. Although this seeming inefficiency of transcriptional initiation, 
which is consistent with Pol II measurements on a lacO array [24], is intriguing, it 
highlights the importance of initiation and promoter pausing as key regulatory control 
events [2]. However, the exact purpose of Pol II idling during initiation and pausing 
remains unknown. The continuous rounds of initiation and termination may contribute to 
keep promoters free of nucleosomes at active genes [6, 50], or alternatively, idling may be 
important to maintain promoter enhancer contacts [51]. Pol II idling at promoters would 
also facilitate transcriptional bursting, which refers to the episodic release of multiple Pol 
II during a short period of time [52, 53]. 
Quantitative framework of the Pol II transcription cycle
In addition to the assessment of Pol II dynamics, endogenous expression of GFP-RPB1 
allowed to estimate the number of nuclear Pol II complexes. This analysis resulted in 
~50,000 in a diploid cell (Fig 1e). With the assumption that productive elongation 
represents a single kinetic step the fraction size of elongating Pol II was modeled to 60%, 
approximating to ~30,000 elongating Pol II. Combined with the expression frequency-
corrected average gene length of 46 kb (see Dataset S1, sheet 2) this suggests that on 
average ~1.1 Pol II are elongating per gene body (Dataset S1, sheet 3). Of note, while 
some less frequently expressed genes are probably not continuously transcribed in every 
cell and therefore do not have an engaged Pol II constantly, other highly expressed genes 
are likely continuously transcribed by multiple Pol II complexes [54]. Modeling further 
indicated that 10% of nuclear Pol II are initiating, and 23% are paused proximal to 
the promoter, which equals to ~16.500 Pol II located at promoter regions. Compared 
to 30,000 Pol II dispersed over the average gene body of 46 kb, these 16.500 Pol II are 
bound to the relatively short promoter region, coinciding with the high density of Pol II at 
the transcription start site observed in Chip-Seq experiments [11].
In summary, we show that GFP-RPB1 KI cells provide a powerful tool to study endogenous 
Pol II in living cells and uncover valuable new insights into the mechanism and the dynamics 
of Pol II initiation and promoter pausing. We demonstrate that photo-bleaching combined 
with modeling is a valuable extension of the existing tools to study the dynamics of Pol 
II transcription. 
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MATERIALS AND METHODS
Generation of GFP-RPB1 knock in (KI) cells and cell culture
KI cells were generated from Sv40-immortalized MRC-5 fibroblasts as described here [19]. 
Detailed protocol in SI Materials and Methods. Cells were cultured in a 1:1 mixture of 
Ham’s F10 and DMEM (Gibco) supplemented with antibiotics and 10% fetal calf serum, 
at 37˚C; 20% O2, and 5% CO2 in a humidified incubator.
Immunofluorescence and EU incorporation
Click it-based EU incorporation was performed as described previously [55]. Detailed 
protocol in SI Materials and Methods. Immunofluorescence was performed as described 
in SI Materials and Methods. Transcription inihibitors, antibodies and respective 
concentrationsare listed in Dataset S2.
Cellular Fractionation, Western Blot Analysis
The fractionation procedure was adapted from [56], and is described in detail in SI Materials 
and Methods. Fractions were separated on a 6% SDS Page gel, blotted overnight at 40V. 
Blots were blocked with 1.5% BSA in PBS and stained with primary antibodies listed in 
Dataset S2. Secondary antibodies were coupled to IRDyes (LiCor) and imaged with an 
Odyssey CLx infrared scanner (LiCor).
Live cell confocal microscopy and quantification of nuclear Pol II
Live cell imaging was performed on a Leica SP5 confocal laser scanning microscope with 
a HCX PL APO CS 63x, 1.40-NA oil immersion lens. Images were recorded with a 488nm 
Argon laser and a 500–600nm bandpass filter. For detailed RPB1 FRAP procedure please 
see SI Materials and Methods. For Pol II concentration measurements eGFP (Biovision) 
was dissolved in PBS, serially diluted in culture medium and the fluorescence intensity 
was measured alongside nuclear GFP-RPB1 fluorescence. For detailed procedure see SI 
Materials and Methods.
Monte-Carlo Modeling
Experimental FRAP curves were fit by least squares, to a large set of computer simulation-
generated FRAP curves that were computed based on a model that simulates diffusion 
of molecules (here Pol II), and binding to and releasing from immobile elements, (here 
chromatin), in an ellipsoidal volume (here the nucleus). For details see SI Materials 
and Methods. 
Detailed protocols for RNA Seq data analysis, Chromatin immunoprecipitation, 
siRNA transfection and RT-PCR can be found in SI Materials and Methods
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SUPPLEMENTAL MATERIALS AND METHODS
Generation of GFP-RPB1 knock in (KI) cells 
A single guide RNA (sgRNA) sequence targeting POLR2A (RPB1) was selected using 
the ZitFit Targeter Program [57]. The sgRNA with overhangs for BbsI restriction was 
inserted into pX330-U6-Chimeric_BB-CBh-hSpCas9 (Addgene plasmid ID: 42230) 
expressing a human codon-optimized Cas9. The homologous repair template, pBs-Rpb1-
LA-Atg-Flag-Ggp-RPB1-RA, was generated using GIBSON assembly of the linearized pBs 
(pBluescript) vector and 3 PCR products encoding the left homology arm (LA), the GFP-FLAG 
linker fragment and the right homology arm (RA), respectively. LA is identical to the 750 
bp upstream of the RPB1 start codon. RA corresponds to the 750 bp downstream of 
the RPB1 start codon but contains 3 silent point mutations (ATG CAC GGG GGT GGC à 
ATG CAT GGA GGG GGC) to prevent Cas9 from re-cutting once RPB1 has been targeted. 
The homology arms were amplified from sequenced sub clones of genomic DNA isolated 
from VH10 cells. 0.9µg of pX330-U6-Chimeric_BB-CBh-hSpCas9_sgRNA and 
3.6µg of pBs-RPB1-LA-Atg-Flag-Gfp-Rpb1-RA were transiently transfected in wild type 
MRC-5 cells with the JetPei transfection reagent (Polyplus-transfection) according to 
manufacturer’s instructions. GFP-positive cells were FACS-sorted and seeded in a limiting 
dilution to 96 well plates to expand single clones. Primers used to genotype single clones 
are listed in Table S2.
Immunofluorescence and EU incorporation
Cells were grown to 80% confluency on glass coverslips, treated as indicated, fixed with 
2% PFA in PBS for 15min at room temperature. After permeabilisation with 0.1% Triton 
in PBS for 10min and blocking in 1.5% BSA and 0.15% glycine in PBS for 15 min cells 
were incubated with primary antibodies as listed in TableS2. After washing in 0.1% triton 
in PBS for 10min cells were incubated with respective secondary antibodies coupled to 
the indicated Alexa fluorophores for 2h at RT. Transcription levels were measured by 
pulse labeling with 5ethynyl uridine (EU) (Jena Bioscience). for 30’ with 1µM EU in Ham’s 
F10 medium supplemented with 10% dialyzed fetal calf serum (Gibco). To measure EU 
corporation after transcription inhibition cells were treated with inhibitors for 1h before 
the EU pulse and inhibitors were present during the EU pulse. Subsequently, cells were 
washed with PBS, fixed with 2% PFA in PBS for 15min. After permeabilisation with 0.1% 
triton in PBS for 10min click chemistry-based azide coupling was performed by incubation 
for 30min with 60µM Atto594 Azide (Attotec, Germany) in 50mM Tris buffer (pH8) with 
4mM CuSO4 (Sigma Aldrich) and 10mM freshly prepared ascorbic acid. Coverslips were 
washed with PBS and mounted with Vectashield containing DAPI (Brunschwieg Chemie). 
Cells were imaged with a Zeiss LSM 700 Axio Imager Z2 upright microscope equipped 
with a 63x Plan-Apochromat oil immersion lens (NA 1.40).
FRAP
For FRAP at pixel size 24.6x24.6 µM a strip of 512x32 pixels spanning the nucleus was 
imaged every 400ms with 400Hz. 25 frames were recorded before the bleach pulse. 
The average, background-corrected fluorescence intensity of frame 10 to 20 of these pre-
bleach measurements were used to calculate the pre-blech fluorescence intensity. GFP 
fluorescence in the strip was bleached for 1 frame with 100% laser power. The recovery 
of fluorescence was monitored for 4min (600frames) within and outside the strip. For 
half nucleus bleach at pixel size 123x123µM an image of 1024x1024 pixels was recorded 
every minute for 120min at 200 Hz. Regions of interest were selected over half nuclei and 
were photo-bleached with 100% laser intensity for one frame. FRAP and FLIP curves were 
corrected for background fluorescence outside the nucleus and normalized to pre-bleach 
fluorescence in the region of interest.
Cellular Fractionation
Cells were lysed in lysis buffer (30mM Hepes pH7.6, 1mM MgCl2, 130mM NaCl, 0.5% 
Triton, 0.5mM DTT, 50µM Mg132, EDTA free protease inhibitor (Roche) and phosphatase 
inhibitor cocktail 2 (Sigma Aldrich)) on ice for 15 min and then scraped in lysis buffer. 
500U of benzonase (Millipore) was added for 1h on ice. For fractionation whole cell 
lysates were centrifuged for 15  min at 13000 rpm and 4°C. Supernatant containing 
nucleoplasmic RPB1 was collected. The pellet containing chromatin-bound RPB1 was 
washed twice with lysis buffer and re-suspended in lysis buffer. Supernatant and pellet 
were diluted with SDS Page loading buffer (4% SDS, 0.2% bromophenol blue, 20% 
glycerol, 200mM β-mercaptoethanol) and separated on separated on a 6% SDS Page gel.
Transfer was done overnight at 4°C and 40V in 2x transfer buffer (25mM TRIS, 190mM 
Glycine) without methanol. Blots were blocked with 1.5% BSA in PBS and stained with 
the same primary antibodies as used for immunofluorescence. Secondary antibodies 
were coupled to IRDyes (LiCor) and imaged with an Odyssey CLx infrared scanner (LiCor). 
Quantification of western blots was done using Odyssey CLx application software 
version 3.0.21 with the following background correction setting: average border with=2, 
segments=all.
Determination of number of nuclear Pol II
Lyophilized eGFP was purchased from Biovison and dissolved in PBS. To determine 
the concentration of fluorescently active molecules we determined by the absorbance at 
489 nm ( ε489 nm = 55,000 M⁻I Cm⁻I ). A 0.4 µM GFP stock solution in culture medium
was serially diluted to 0.3, 0.2, and 0.1 µM. Z-stacks of GFP-RPB1 cells were recorded in 
medium containing free GFP at a pixel size of 82x82 µM at 200Hz. Fluorescence intensities 
of free extracellular GFP was quantified alongside nuclear GFP-RPB1 fluorescence using 
the LAS AF Lite software. The nuclear volume of MRC-5 cells was determined from 
z-stacks of MRC-5 cells after segmenting the nucleus using a Gaussian blur with a radius
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of 2 pixels and a fixed threshold. To get the number of nuclear Pol II for a diploid cell 
the number of measured nuclear Pol II was corrected for the hyper-tetra-ploidy of MRC-5 
cells, which showed an average chromosome count of 75 after chromosome spread.
Chromatin Immunoprecipitation
Chromatin was cross-linked using 1% formaldehyde in culture medium for 10min. 
Crosslinking was quenched by adding glycine to a final concentration of 0.125M for 5 min. 
Cells were washed twice with PBS and scraped in PBS before pelleting by centrifugation. 
Pellets were lysed for 10 min. in sonication buffer (0.1% SDS, 10mM Tris-HCL pH8, 1mM 
EDTA, 0.5mM EGTA) including complete protease inhibitor cocktail without EDTA (Roche), 
phosphatase inhibitor cocktail 2 and 3 (Sigma). Samples were sonicated for 15 min using 
Bioruptor (Diagenode, 15 sec on, 15 sec off, amplitude High) to fragments of 200-500 
base pairs and centrifuged for 10 min at 14000 rpm to collect chromatin. Chromatin was 
diluted using dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2mM EDTA, 16.7mM 
Tris-HCL pH8, 167mM NaCl) and pre-cleared for 30min using Pierce Protein G Agarose 
beads (Thermo Scientific). RPB1 was immuno-precipitated overnight at 4°C using 5 µg 
GFP antibody (5mg/ml, ab290, Abcam) and for an additional hour with Pierce Protein 
G Magnetic beads (Thermo Fisher). Precipitates were washed for 3 min with low salt 
buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCL pH8, 150mM NaCl), 
high salt buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCL pH8, 500mM 
NaCl), lithium chloride buffer (0.25M LiCl, 1% NP-40, 1% Sodium Deoxychelate, 1mM 
EDTA, 10mM Tris-HCL pH8) and twice with Tris-EDTA buffer (10mM Tris-HCL pH8, 1mM 
EDTA). DNA was eluted from beads twice using elution buffer (1% SDS, 0.1M NaHCO3) 
and decrosslinked for 4h with NaCl at 65°C and 950rpm in a thermoshaker. Proteins 
were removed by incubating 1h at 45°C and 700rpm with Proteinase K, Tris-HCL pH 
6.5 and EDTA before cleaning the DNA using a DNA ChIP Clean & Concentrator kit 
(Zymo Research). 
siRNA Transfection and RT- PCR
Cells were transfected with siRNA using the Lipofectamine RNAiMAX reagent according 
to manufacturer’s instruction. Experiments were performed 48h after transfection. 
Knockdown efficiency was checked by qPCR. siRNA and primer sequences are listed 
in Table S2. mRNA expression levels were normalized to B2M (Beta-2-Microglobulin). 
qPCR was performed using the CFX96 Touch™ Real-Time PCR Detection System (Biorad) 
and PowerUp SYBR green master mix (Thermo Fisher). Primers are listed in Table S2 and 
the used program was: 50°C for 2 min, 95°C for 2 min, 45 cycles of 15 sec at 95°C and 1 
min at 58°C followed by a dissociation curve: 95°C for 10 sec, 65°C for 5 sec and heating 
from 5°C to 95°C. 
Monte-Carlo-based computational Model of Pol II kinetics
To simulate photo-bleaching the three-dimensional intensity profile of the focused 
laser beam was experimentally determined by bleaching fixed cells that expressed GFP, 
as well as cells expressing H2B-GFP, using a stationary laser beam. Care was taken to 
avoid saturation (in this experiment reflected by complete photo-bleaching in the focus). 
The obtained fluorescence intensities before and after the bleach were used to determine 
the probability per unit time for a GFP molecule to get bleached considering its 3-D 
position within the focused laser. The size of the ellipsoid model nucleus (x-, y- and 
z-diameters) was based on averages from experimental data. The simulation of the FRAP
curve was run using discrete time steps of 20 ms. Diffusion was simulated at each new
time step t  +  ∆t by deriving new locations (xt+∆t,  yt+∆t,  zt+∆t) of mobile molecules from
their current positions (xt, yt, zt) by xt+∆t = xt + G(r1), yt+∆t = yt + G(r2), and zt+∆t = zt + G(r3),
where ri is a random number (0 ≤ ri ≤ 1) chosen from a uniform distribution, and G(ri)
is an inversed cumulative Gaussian distribution with s2 = 2D∆t, where D is the diffusion
coefficient. A fixed diffusion coefficient of 2.0 µm2/s was used based on the estimated
molecular weight the Pol II complex and based on previous measurements of free GFP
and chains of GFP and a non-fluorescent GFP variant with increasing molecular weight
[26]. Immobilization was simulated using simple binding kinetics described by: kon/
koff = Fimm / (1 - Fimm), where Fimm is the relative number of immobile molecules. The probability
for each particle to become immobilized (representing chromatin-binding) per unit time
is Pimmobilise = kon = koff 
. Fimm /  (1 - Fimm), where kon and koff are effective on- and off-rates
with dimension s-1, koff = 1 / Timm, and Timm is the average time spent in the immobile state.
The probability per unit time to be released is Pmobilise = koff = 1 / Timm. In simulations of
two or three immobile fractions with different kinetics, three immobilization/mobilization
probabilities were evaluated each unit time step. Simulations of the FRAP curve were
performed at every unit time step by counting the number of unbleached molecules in
the bleached region after simulations of diffusion and binding during that time step. In
addition, three pairs of on- and off-rates were used representing short, medium and long
residence times in immobile state and corresponding fractions (see above). The fraction
with long residence time (long fraction) was then determined by taking the average of
the ten best fitting simulated curves. Simulations were then run again with fixed long
fraction size, and subsequently, the residence time corresponding to this fraction was
determined by taking the average of the ten best fitting curves. Subsequently, new
simulations were run with fixed on- and off-rates corresponding to the determined
fraction and long residence time. This procedure was repeated for the fractions with
medium and short residence times.
RNA-Seq data analysis
Nascent RNA sequencing data from human wild type foreskin fibroblasts (HF1) (GEO: 
GSM1612077, run SRR1806546) [39] was trimmed using TrimmomaticSE v0.32 [58] with 
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the steps: “ILLUMINACLIP:<illumina_adapter_list_file>:2:40:15 LEADING:3 TRAILING:3 
MINLEN:15”. The data was then aligned to the hg19 reference genome using bowtie2 
v2.2.6 [59] with the --local option. Stranded reads (ignoring duplicates) with a minimum 
2 base overlap for any transcript variant of each gene were counted. Individual genes with 
multiple non-overlapping transcripts were excluded. RPKM was computed using the total 
number of mapped reads counted. The per gene read distribution was computed as 
a fraction of all counted reads and the individual gene reads per kilobase were computed 
based on the length of the combined gene transcript variants.
RNA isolation and sequencing 
Total RNA was isolated in duplicate from a mixed population of MRC5 wild type cells, 
a single clone of MRC5 WT cells, and 2 single clones of MRC5 GFP-Rpb1 knock in cells 
using the miRNeasy Mini Kit (Qiagen) according to manufacturer’s instructions. Total RNA 
concentration and quality was determined with an Agilent 2100 Bioanalyzer using a RNA 
6000 Nano LabChip. Sequencing libraries were prepared using the Illumina TruSeq Total 
RNA-seq library preparation kit according to the manufacturer’s protocol. The 150-bp 
pair-ended sequencing files from the Illumina system were quality checked by FastQC 
(v0.11.3) (available online at: http://www.bioinformatics.babraham.ac.uk/projects/
fastqc). Low quality reads and sequencing adapters were removed by Trimmomatic 
(v0.35)[58] and the resulting FASTQ files were aligned to the human reference genome 
(hg19) using Tophat (v2.0.9)[60]. The aligned reads were analysed by HTseq (v.0.6.0) [61]
to quantify gene expression. Genes with less than 5 reads were removed. Differentially 
expressed genes were identified with Deseq (available online at: https://bioconductor.org/
packages/3.7/bioc/vignettes/DESeq/inst/doc/DESeq.pdf) with a cut-off of Log2FC (fold 
change) > 1.5 and P-value <0.05. The statistics plots were created by Rstudio (v0.99.486) 
(Team, R. (2015). RStudio: integrated development for R. Available online at http://www. 
rstudio. com.
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Supplemental Figure 1. Schematic representation of GFP-RPB1 KI strategy: CRISPR associated 
protein 9 (Cas9) is targeted to the POLR2A locus by a specifically designed single guide RNA (sgRNA). 
Cas9 induces a double strand break (DSB) directly downstream of the POLR2A start codon (ATG). 
The DSB can be repaired by homologous recombination (HR) using the repair template containing 
the GFP-FLAG sequence for homology. The right homology arm (RA) of the repair template contains 
three point mutations to prevent Cas9 from re-cutting after HR. The left homology arm (LA) is 
identical to the 750 bp upstream of the sgRNA target site. Schematic procedure of Cas9-mediated 
GFP-labelling of RPB1 in MRC-5 cells. A plasmid expressing the sgRNA and Cas9 was co-transfected 
with a repair template into MRC-5 cells. GFP positive cells were isolated using fluorescence-
activated cell sorting and seeded as single cells into a 96-well plate by limiting dilution. Single cells 
were expanded and subsequently genotyped. GFP-RPB1 knock-in (KI) was checked by genotyping 
genomic DNA of MRC-5 wild type (WT) and KI cells by PCR with the indicated primers (top panel). 
PCR products were analysed by DNA gel-electrophoresis (bottom panel). Representative images 
of cells that were pulse labeled with EU for 1h followed by click-chemistry-based EU coupling to 
ATTO594 of non-treated MRC5 wild type (WT) or GFP-RPB1 knock in (KI) cells. DNA was stained 
with DAPI, RPB1 was visualized by αGFP immunostaining. Pearson correlation coefficients (left) and
principal component analysis (right) of RNA expression levels of a mixed population of MRC5 wild 
type (WT) cells, a single cell clone of MRC5 WT cells (WT_CL), and 2 single cell clones of MRC5 cells 
expressing GFP-RPB1 (KI_CL).  To replicates of each sample were analysed. 
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Supplemental Figure 2. Representative images of cells that were pulse labeled with EU for 1h 
followed by click-chemistry based EU coupling to ATTO594 of non-treated (NT) KI cells and after 
treatment with the indicated transcription inhibitors. DNA was stained with DAPI, RPB1 was 
visualized by αGFP immunostaining. Quantification of EU incorporation shown in S2b (left panel) 
and quantification of GFP fluorescence (right panel). FI= Fluorescence intensity, mean ±SEM, n>55 
cells. Fluorescence recovery after photo-bleaching (FRAP) of the bleached and fluorescence loss 
in photo-bleaching (FLIP) of the non-bleached half of nuclei of non-treated (NT) cells and cells 
treated with 100µM Cordycepin for 90 min are plotted against time. RFI=Relative fluorescence 
intensity, mean of n=10 cells . Relative TFIIS mRNA levels measured by qPCR of the TFIIS paralogues 
TCEA1 and TCEA2 after siRNA-mediated knockdown. Values are normalized to TCEA1 and TCEA2 
expression of cells transfected with a non-targeting siRNA. Propidium-Iodide content-based cell 
cycle distribution of non-treated (NT) MRC5 cells or cells treated with 1µM of THZ1 for 1.5 hr.
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Supplemental  Figure  3 
Supplemental Figure 3. Fitting of FRAP curves described in Figures 2c, 4a, and 4b to the best 
fitting curve generated by MC-based modeling. MRC5 GFP-RPB1 knock in cells were non-treated 
(NT) (a) or treated for 1hr with 1µM THZ1(b), 1µM Flavopiridol (c), or 100µM Cordycepin (d). Cells 
were treated for 2hr with 100µg/ml α-Amanitin with (f) or without (e) pre-treatment with 50µM 
Mg132 for 1 hr. Cells were treated for 1hr with 0.5µM Tritptolide with (h) or without (g) pre-
treatment with 50µM Mg132 for 1 hr, or after pre-treatment with 1µM THZ1 for 1hr (i). Residuals 
represent the squared differences between measured and simulated FRAP curves. Errors of all MC-
modeled fraction sizes of the long bound Pol II fraction in NT or inhibitor-treated cells as described 
above. The 10 fraction sizes with the smallest error, i.e.  the best fit, that were averaged for Fig 3b, 
are marked in magenta (j-m).
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Supplemental  Figure 4
Supplemental Figure 4. Residence times and fraction sizes of Pol II fractions obtained from 
MC-based modelling of 20 cells of 2 experiments (NT original, same as NT Fig 2c), the average of
three individually modeled FRAP curves (NT avg. NT1,2, and3), and 3 individually modeled FRAP 
experiments (NT1, NT2, and NT3). NT1,2,3 and NT original show the mean ±SD of the 10 best fits. 
NT avg NT1, 2, and 3 represents the mean ±SD of the individually modeled parameters. Residence 
times (middle panel) and fraction sizes (right panel) of Pol II fractions obtained from MC-based 
modelling of one individual FRAP curve without or with addition of  gaussian noise (σ=2). Bottom
panel: Western blot after cell fractionation of non-treated (NT) MRC5 KI cells or cells treated 
with the indicated inhibitors for 90 min. Top panel: Fraction sizes  of chromatin-bound (Pel) and 
nucleoplasmic (Sup) Pol II after fractionation and western blot analysis compared to fraction sizes 
predicted by MC-based modeling (Fig 3b). The long bound fraction is presented as chromatin-bound, 
whereas the sum of the free, short, and medium bound fractions is presented as nucleoplasmic. 
NTD= N-terminal domain. Mean ±SD of 3 Western Blots. One representative western blot is shown.
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Supplemental Figure 5. Representative images of cells that were pulse labeled with EU for 
1h followed by click-chemistry-based EU coupling to ATTO594 of non-treated (NT) KI cells and 
after treatment with the indicated transcription inhibitors. DNA was stained with DAPI, RPB1 was 
visualized by αGFP immunostaining. Quantification of ATTO594 and GFP fluorescence intensities
are plotted in the chart in the right. mean ±SEM, n>50 cells FRAP of GFP-RPB1 in non-treated 
(NT) cells and cells treated with the proteasome inhibitor Mg132 (left panel). Column chart shows 
mean ±SD of the pre-bleach fluorescence intensities (FI) of 10 cells analysed by FRAP as a measure 
of Pol II protein levels (right panel).  Western blot of GFP-RPB1 KI whole cell lysates after indicated 
treatments. All samples originate from the same blot. NT= non-treated. Mg132 =proteasome 
inhibitor. and e. Residence times of short bound, medium bound, and long bound Pol II fractions 
obtained from Monte Carlo-based modeling of GFP-RPB1 FRAP data (Fig 3a,c, and e) in NT KI cells or 
after treatment with Triptolide (d) or α-Amanitin (e). Mean ±SEM of the 10 best fitting simulations.
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ABSTRACT 
UV light induces cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone (6-4) 
photoproducts (6-4PPs), which can result in carcinogenesis and aging, if not properly 
repaired by nucleotide excision repair (NER). Assays to determine DNA damage load and 
repair rates are invaluable tools for fundamental and clinical NER research. However, 
most current assays to quantify DNA damage and repair cannot be performed in real 
time. To overcome this limitation, we made use of the damage recognition characteristics 
of CPD and 6-4PP photolyases (PLs). Fluorescently-tagged PLs efficiently recognize UV-
induced DNA damage without blocking NER activity, and therefore can be used as 
sensitive live-cell damage sensors. Importantly, FRAP-based assays showed that PLs bind 
to damaged DNA in a highly sensitive and dose-dependent manner, and can be used to 
quantify DNA damage load and to determine repair kinetics in real time. Additionally, PLs 
can instantly reverse DNA damage by 405 nm laser-assisted photo-reactivation during 
live-cell imaging, opening new possibilities to study lesion-specific NER dynamics and 
cellular responses to damage removal. Our results show that fluorescently-tagged PLs 
can be used as a versatile tool to sense, quantify and repair DNA damage, to study NER 
kinetics and UV-induced DNA damage response in living cells.
INTRODUCTION
Our genome is continuously exposed to various types of DNA damage. If not repaired 
correctly, DNA lesions may result in mutations, cellular senescence or cell death, which 
can eventually lead to various pathological conditions including carcinogenesis and aging 
[1]. To counteract these deleterious effects of DNA damage, cells have evolved a variety of 
mechanisms, including several DNA repair pathways [2]. Nucleotide excision repair (NER) 
is one of the most versatile DNA repair pathways, as it removes a wide variety of DNA 
helix-destabilizing lesions. Prominent examples of NER substrates are the UV-induced 
cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone (6-4) photoproducts 
(6-4PPs). The biological importance of NER is illustrated by the severe clinical symptoms of 
human disorders caused by inherited NER defects, including the cancer-prone xeroderma 
pigmentosum (XP) syndrome or the premature aging disorder Cockayne’s syndrome 
(CS) [3]. 
NER is initiated by two sub-pathways that differ in their mode of damage recognition. 
Global genome NER (GG-NER) detects lesions in the entire genome, by the main DNA 
damage binding protein XPC [4]. XPC recognizes DNA-helix distortions such as induced 
by 6-4PP lesions, but needs the activity of the UV-DDB complex, composed of DDB1 and 
DDB2, to detect mildly helix-destabilizing CPD lesions [5, 6]. Transcription-coupled NER 
(TC-NER) is initiated when DNA damage located in the actively transcribed strand blocks 
elongating RNA polymerase II, which results in the recruitment of the TC-NER factors 
CSA, CSB, and UVSSA [7, 8]. Once the DNA lesion is recognized, general transcription 
factor II H (TFIIH) is recruited [9, 10] to unwind the DNA surrounding the damage [11] 
and to verify the lesion together with XPA [12, 13]. The endonucleases XPG and ERCC1/
XPF subsequently remove a ~30 nucleotide long fragment of DNA around the lesion 
[14]. Finally, the DNA is restored back to its original state by DNA synthesis and ligation 
steps [15, 16].
Recent studies have shown that NER is a tightly regulated, multistep pathway that 
requires many proteins and post-translational modifications for the efficient and accurate 
transition between the successive reaction steps [3, 17-19]. Additionally, as NER takes place 
in the complex chromatin and nuclear environment, many factors involved in chromatin 
remodeling [3, 20, 21], transcription [22], or replication [23] influence NER activity, and 
most likely many other involved factors are awaiting their discovery. Therefore, assays 
to quantify DNA damage and repair rates are invaluable tools to investigate the roles of 
such factors and to obtain new fundamental insights into the molecular mechanism of 
NER. Moreover, assays to detect impairments or deficiencies in NER activity have been 
crucial for the diagnosis of NER-deficient patients and can be used as indicators for 
predispositions to mutations, the onset of cancer, or DNA damage-induced aging [24-27].
Over the years, several assays were developed to quantitatively monitor UV-
induced DNA damage and NER-mediated repair. Traditionally NER activity is measured 
by determining the rate of UV-induced DNA repair synthesis, the last step of the NER 
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reaction [28-30], or by determining the levels of CPDs in the DNA in time using T4 
endonuclease V [31]. Over the years several other assays have been developed to 
monitor upstream NER activity, including UV-damage removal [32], NER-induced 
incisions [33] or quantification of excision products [34]. TC-NER is often determined 
indirectly by quantifying the recovery of RNA synthesis (RRS) [35, 36], or by using host 
cell reactivation assays [37]. Alternatively, TC-NER can be measured in a direct manner 
by strand-specific repair assays [38], or by more recently developed single-cell assays, 
such as the modified COMET-FISH procedure [39], or the TC-NER specific UDS assay [40]. 
Direct detection and quantification of UV-induced DNA damage and its removal in time 
can be accomplished using antibodies specifically recognizing CPD or 6-4PP lesions in 
combination with immunofluorescence or ELISA procedures [32]. Although proven to 
be useful in studying UV-induced DNA repair, these assays depend highly on the quality 
of the antibodies and have specific limitations. For instance, antibody-based detection 
of CPD or 6-4PP lesions requires DNA denaturation, to allow DNA damage recognition 
by these antibodies. For example in immunofluorescence experiments, this denaturation 
may interfere with co-staining of other proteins of interest. Importantly, most of these 
assays require cell fixation, which makes them incompatible with live-cell applications, 
and therefore can only provide endpoint measurements. To overcome these issues, 
measurements of the DNA damage binding kinetics of fluorescently-tagged NER factors 
can be used to evaluate repair activity in living cells [41-43]. However, these binding 
kinetics do not provide a direct measurement of DNA damage quantities, as the DNA 
damage-induced binding of the NER proteins is not influenced exclusively by the DNA 
damage load, but can also be regulated by post-translational modifications or chromatin 
remodelers [42, 44-49].  
While NER is the only mechanism to repair UV-induced DNA damage in placental 
mammals, an alternative damage removal mechanism known as photo-reactivation (PR) 
remained preserved through evolution in other branches of life, ranging from bacteria to 
non-placental mammals, [50, 51]. In contrast to NER-mediated repair, which is a complex 
mechanism that requires the activity of at least 30 proteins [3], PR is the direct reversal 
of CPD or 6-4PP lesions by one single damage specific photolyase (PL). PLs recognize 
the helix distortions created by CPD and 6-4PPs and bind to them through moderately 
strong ionic interactions. These interactions further destabilize the distorted DNA helix 
and lead to a flipping out of the DNA lesion into the active site of the PL, forming 
a highly stable complex [52, 53]. In contrast to the binding of PLs to DNA lesions, 
which is independent of light, the catalytic reversal of pyrimidine dimers to the original 
bases requires the absorption of a photon. Catalysis by PLs is achieved by light-initiated 
cycloconversion of the cyclobutane ring joining the two pyrimidines, which encompasses 
first the adsorption of a 333-500 nm photon by the chromophore MTHF, second the energy 
transfer from the blue light photon to the Flavin cofactor (FADH-), and third the electron 
transfer from FADH- to the cyclobutane ring, which splits the pyrimidine dimer and forms 
a flavin radical (FADH·). The catalytic cycle is completed when the electron is transferred 
back to the cofactor, restoring catalytically active, fully reduced FADH- [53-55]. The entire 
reaction takes ~1 ns for both types of PLs [53]. The repair-independent binding of PLs to 
CPDs or 6-4PPs and their very fast damage removal makes PLs an attractive tool to study 
UV-induced damage and its repair. However thus far, PLs have mainly been used to test 
the specific cellular responses to either CPD or 6-4PP after removing the other type of 
lesion by PR [56-59]. 
Here we show, that fluorescently labelled PLs provide a versatile and sensitive tool 
to locate, quantify and repair UV-induced DNA damage in real time in living cells. 
Fluorescence recovery after photobleaching (FRAP)-based mobility studies of PLs allow 
to quantitatively determine DNA damage load, as well as repair kinetics. Furthermore, 
we show that PLs can be activated by the 405 nm laser light during live cell imaging 
experiments to photo reactivate DNA damage, which facilitates studying the behavior of 
NER factors and the DNA damage response upon DNA repair in living cells.
MATERIAL AND METHODS
Cell Lines and Constructs
VH10 hTERT immortalized human fibroblasts, XP4PA SV40 immortalized XP-C fibroblasts 
and HCT116 human colon cancer cells were cultured in DMEM/F10 and RPMI/F10 
media, respectively, containing 10% FCS and 1% penicillin-streptomycin in a humidified 
incubator at 37oC and 5% CO2. To generate a lentiviral 6-4PP-PL-mCherry-3xNLS-
HA expression vector, Arabidopsis thaliana 6-4PP-PL cDNA [60], missing the first 57 
nucleotides corresponding to a mitochondrial localization signal, was first cloned into 
pENTR/D-TOPO vector (Invitrogen). mCherry-3xNLS-HA was ordered as gBlocks Gene 
Fragment (Integrated DNA technologies) and ligated to the C-terminal of 6-4PP-PL cDNA 
in the pENTR/D-TOPO vector, using AscI and EcoRI. Then 6-4PP-PL-mCherry-3xNLS-HA 
was cloned into pLenti CMV Puro DEST using Gateway cloning (Invitrogen). CPD-PL-
mCherry [48], or 6-4PP-PL-mCherry-3xNLS-HA expressing lentiviral vectors were used to 
make the corresponding lentiviruses using the third generation system [61]. GFP-DDB2 
expressing VH10 cells [44], or GFP-XPC expressing HCT116 cells were transduced with 
the generated lentiviruses and cells stably expressing CPD-PL-mCherry or 6-4PP-PL-
mCherry-3xNLS-HA were selected with puromycin. 
GFP-XPC expressing HCT116 cells were generated by a CRISPR/Cas9 mediated 
knock-in strategy where HCT116 cells were co-transfected with a lentiCRISPR 
v2 vector containing an XPC guide RNA (5’-GCTCGGAAACGCGCGGCCGG-3’) 
targeting right after the XPC start codon and, a linearized homology-directed repair 
(HDR) template. GFP-XPC DDB2-/- HCT116 cells were generated by transfection of 
GFP-XPC HCT116 cells with a lentiCRISPR v2 vector containing a DDB2 guide RNA 
(5’-TATTACGCCCCAGGAACAAG-3’). The HDR template to generate a GFP-XPC knock-in 
was generated in a single PCR step using 200 bp primers. The primers were designed in 
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a way that 30 bp of each primer anneals to the FLAG-GFP construct and the remaining 
170 bp anneals to the human genomic XPC sequence. Furthermore, the PAM sequence 
was mutated by 5 silent mutations which were introduced in the region targeted by 
the XPC gRNA to prevent Cas9 cutting the integrated HDR template. The following primers 
were used to generate the HDR template: forward primer (5’CCGCAGTTTTTTAGTG 
GCCACGGGTATGGGGTGGAGCTTCCTTTAGGGGCGTGACTAGGCCTCCAACGA 
AGGGGCGTGGCCAAGCGCACCGCCTCGGGGCGGGGCCGGCGTTCTAGCG 
CATCGCGGCCGGGTGCGTCACTCGCGAAGTGGAATTTGCCCAGACAAGCA 
ACATGGACTACAAGGACGACGATGACAAGGTG-3’), reverse primer (5’-GCCTCTGGGCC 
TCCTCCGCCCACCGGCGGCGTCTCCCGCGAAGCCCGCTGGGCCTCGCTCTCACCCTCC 
TCCTCCTCCTCACGCCGGGCCTTGCTCTTGGCCTTGGATTTCTGGCTGCGCAGTTCG 
CGTCCCCGCGGCTCCCCGCCTGCGGCTCTCTTCCGAGCGAGATGCTTGTACAGCT 
CGTCCATGCCGAGAGTGAT-3’). The PCR generated template was cloned into pCR-Blunt 
II-TOPO vector and then the vector was digested with EcoRI to generate the linearized 
GFP-XPC construct. 
Transfected HCT116 cells were selected by puromycin for 2 days and stable GFP-XPC 
expressing cells were FACS sorted. Then single cell clones were picked and clones were 
selected using genotyping, and western blotting to check for expression of the full-length 
GFP-XPC protein and the concomitant loss of wild type XPC expression. 
RNA interference
Cells were transfected with the indicated siRNAs (150 pmol) using RNAiMax (Thermo 
Fisher Scientific) 48-72h prior to the experiment, according to manufacturer’s protocol. 
The siRNAs were purchased from Dharmacon: control (siGENOME Non_Targeting 
siRNA#5, D-001210-05) and XPF (siGENOME ERCC4 siRNA, M-019946-00).
Inflication of UV-induced DNA damage 
Cells were washed with PBS, and after PBS removal the cells were exposed to UV-C light 
from a 254 nm germicidal lamp (Philips). Local UV-C damage was inflicted through an 
isopore membrane filter (Millipore) with a pore size of 5 µm [62].  
Photo-reactivation
After PBS wash, cells were covered with a thin layer of HBSS (Thermofisher) and then 
placed at a distance of 10 cm under white-light tubes (General Electric Lightning Polylux 
LX F36W/840) for 10 minutes at 37oC. Mock-treated samples were covered with aluminum 
foil during photo-reactivation (PR).
Western blotting
Cells were lysed in 2x sample buffer and boiled for 10 minutes at 95oC. The proteins were 
subsequently separated by SDS-PAGE and transferred to PVDF membranes (0.45 μm). 
Membranes were blocked with 5% BSA in PBS-T (PBS containing 0.05% Tween 20) for 1 
hour at room temperature (RT) and blotted with the following primary antibodies: CPD-PL 
and 6-4PP-PL (rabbit polyclonal, 1:500) [58, 59], RFP mCherry (rat monoclonal, 1:1000, 
5F8, Chromotek), DDB2 (rabbit monoclonal, 1:1000, EPR981, abcam), Ku70 (goat 
polyclonal, 1:1000, M-19, sc-1487, Santa Cruz), tubulin (mouse monoclonal, 1:3000, 
B-5-1-2, sc-23948, Santa Cruz), XPC (rabbit polyclonal, 1:1000, A301-122A, Bethyl) or 
XPF (mouse monoclonal, 1:500, 3F2/3, sc-136153, Santa Cruz). After five times washing 
with PBS-T, the membranes were blotted with the following corresponding secondary 
antibodies from Sigma Aldrich: CF™ 680 Goat anti-Rabbit IgG (1:5000) and CF™ 770 
Goat anti-Mouse IgG (1:5000).. The blots were imaged with the Odyssey CLx Infrared 
Imaging System (LI-COR Biosciences).
Immunofluorescence
Cells were grown on 24 mm coverslips and fixed in 2% paraformaldehyde containing PBS 
Triton X-100 (0.1%). After five times washing with PBS Triton X-100, the coverslips were 
blocked in PBS+ (PBS containing 0.15% glycine and 0.5% BSA). A denaturation step of 5 
minutes using freshly diluted NaOH (0.07M) in PBS was performed to make DNA lesions 
accessible for the CPD (mouse monoclonal, 1:1000, TDM-2, Cosmo Bio) or 6-4PP (mouse 
monoclonal, 1:300, 64M2, Cosmo Bio) primary antibodies. Following an incubation of 
1-2h at RT with primary antibodies diluted in PBS+, the coverslips were washed with PBS 
Triton X-100 five times and PBS+ once. Then the coverslips were incubated with 488, 
555 or 639 Alexa Fluor secondary antibody conjugates (Invitrogen) diluted in PBS+ for 1h 
at RT. After the coverslips were washed again as described above, they were embedded 
in Vectashield Mounting Medium with DAPI (Vector Laboratories). The coverslips were 
imaged using a LSM 700 microscope equipped with a Plan-Apochromat 40x/1.3 NA oil 
immersion lens (Carl Zeiss MicroImaging Inc.).  The ImageJ software [63] was used to 
quantify the CPD and 6-4PP signals in the generated images. The DAPI signal was used to 
determine the nuclei and the mean fluorescence intensities measured in the nuclei were 
used to plot the graphs. For CPD and 6-4PP removal assay cells were globally UV irradiated 
with 10J/m2 and 16 10J/m2 respectively, and fixed after the indicated time points. CPD and 
6-4PP staining was performed as described above. Fluorescence levels were quantified 
in at least 70 cells per sample by measuring the background-corrected overall nuclear 
fluorescence, which was set at 100% for 0 h after UV irradiation.Colony survival assay 
Cells were seeded in triplicate in 6-well plates (300 cells/well) and next day treated 
with the indicated UV-C doses. After a week, the colonies were fixed and stained with 
0.1% Brilliant Blue R (Sigma), and counted using GelCount (Oxford Optronix Ltd.).
Live cell confocal laser-scanning microscopy
All live cell imaging experiments were performed at 37oC and 5% CO2 using a Leica SP5 
laser-scanning confocal microscope with a 63×/1.4 NA HCX PL APO CS oil immersion 
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objective. Fluorescence recovery after photobleaching (FRAP) experiments were performed 
as described previously [42], in short; a narrow strip (512 x 16 pixels at zoom 9) along 
the nucleus was bleached 94 ms with 100% power of 488 nm laser for the GFP and 42 
ms with 100% power of 561 nm laser for the mCherry signal. The signal in this strip was 
measured pre-bleach for 3.6 s and post-bleach for 20 s every 400 ms with 0.2% power 
of the 488 nm laser for GFP-XPC. FRAP of the mCherry-tagged PLs was performed by 
measuring pre-bleach for 2.5 s and post-bleach for 20 s every 100 ms with 3% power 
of the 561 nm laser for the mCherry signal of the PLs. To analyze fluorescence recovery, 
measured fluorescence intensities were first background corrected, then normalized to 
the average pre-bleach fluorescence signal which was set at 1. Immobile fractions were 
calculated using the following formula: Immobile fraction (%) = 1 − ((average fluorescence 
intensity of UV-C irradiated cells − the first post-bleach data point) / (average fluorescence 
intensity of mock-treated cells−the first post-bleach data point)). The average fluorescence 
intensities are calculated over the measurements of the last 10 s. For local repair during 
live cell imaging experiments, the fluorescence intensity of PL-mCherry was monitored 
every 2.585 s, both inside and outside the local damage within the nucleus (at zoom 
10). PR was performed by exposure of the DNA damage to 5 frames of 5% 405 nm laser 
light. The power output of the 405 nm laser was measured to be 0.063 mW at 10% 
laser power. Data were corrected for background fluorescence signal outside the cell and 
normalized to average fluorescence signal at the local damage before PR, which was set 
at 1.
RESULTS
Generation and characterization of CPD-PL and 6-4PP-PL-expressing cells
To develop a method to quantify UV-induced DNA damage and its repair kinetics directly 
in living cells, we first tested whether the ability of PLs (PLs) to specifically detect UV-
induced lesions could be exploited to generate live cell damage markers by fluorescently 
labeling them. For this purpose, we generated lentiviral vectors [64] expressing Potorous 
tridactylis CPD-PL [58] or Arabidopsis thaliana 6-4PP-PL [65] tagged with mCherry 
fluorescent protein at their C-terminus. In addition, 3 NLS sequences were added after 
the mCherry-tag of the 6-4PP PL to ensure nuclear expression. These lentiviruses were 
used to transduce GFP-DDB2 expressing VH10 (hTERT immortalized human fibroblast) 
cells [44] to stably express either CPD PL-mCherry or 6-4PP PL-mCherry (referred as 
CPD-PL or 6-4PP-PL, respectively). Western blot analysis showed that the generated VH10 
cell lines express full-length PL-mCherry fusion proteins (Figure 1A). To be able to use 
these PL-mCherry proteins as UV damage markers, it is important that PL expression does 
not interfere with NER-mediated repair of UV-induced lesions. As shown by UV colony 
survival experiments, both CPD-PL and 6-4PP-PL-expressing cells showed a similar UV 
sensitivity as wild type (WT) VH10 cells (Figure 1B), indicating that the expression of these 
fusion proteins does not affect endogenous DNA repair activity. To corroborate this, we 
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Figure 1. Characterization of mCherry-tagged photolyase-expressing cells. (A) Western blot of 
lysates of VH10 cells stably expressing GFP-DDB2 (WT), or co-expressing GFP-DDB2 and either 
CPD-PL-mCherry (CPD-PL, upper panel, expected size 75kDa) or 6-4PP-PL-mCherry (6-4PP-PL, lower 
panel, expected size 85kDa). Blots were stained with the indicated antibodies. Relevant marker sizes 
are indicated and * indicates an unspecific band. (B) UV-C sensitivity of WT or PL-expressing VH10 
cells, determined by colony-forming ability (mean ± SEM). Percentage of surviving cells is plotted 
against the applied UV-C dose, colony number at 0 J/m2 is set at 100 %. (C and D) Representative 
images of WT and PL-expressing VH10 cells. Cells were either non-irradiated (no UV, left panel) 
or locally irradiated with 60 J/m2 UV-C (Local UV, right panel). Cells were either fixed directly after 
DNA damage induction (C) or monitored directly by live cell imaging (D). Arrows indicate local UV 
damage. Scale bar: 5 μm.
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compared the kinetics of 6-4PP and CPD removal in PL-expressing cells and WT VH10 cells 
(Supplementary Figure S1A and B). This revealed that the endogenous repair of CPDs and 
6-4PPs by NER was similar in PL-expressing cells and in wild type cells, but was strongly 
diminished in NER deficient XP-C cells.
The fusion to a mCherry tag allowed direct visualization of PLs and showed that both 
CPD-PL and 6-4PP-PL are expressed mainly in the nucleus (left panels of Figure 1C and D). 
While the CPD-PL is excluded from the nucleoli, the 6-4PP-PL was enriched in the nucleoli 
(bottom panels of Figure 1C and 1D), however, the mechanism behind this different 
nucleolar localization is unknown. As PLs bind CPDs and 6-4PPs light independently, 
but need white light to initiate catalysis, we subsequently tested whether the PLs were 
capable of binding to UV-induced DNA damage, while cells were kept in the dark. Both 
CPD-PL and 6-4PP-PL accumulated at local UV damage induced through micropore filters 
[62], as shown by a co-localization with the DNA damage recognizing protein DDB2 
(Figure 1C, right panel). Of note, the exogenous expression of the PLs did not block DDB2 
recruitment to sites of DNA damage. Furthermore, both CPD-PL and 6-4PP-PL co-localized 
with the respective lesion-specific antibodies (Supplementary Figure S1C). Importantly, 
CPD-PL and 6-4PP-PL were efficiently recruited to locally induced DNA damage in living 
cells (Figure 1D, right panel), demonstrating that PLs can be used to directly detect UV-
induced CPD and 6-4PP lesions in living cells, which is not possible with photo lesion-
specific antibodies.
CPD-PL and 6-4PP-PL as quantitative, real-time, damage and  
repair markers in living cells
Both CPD-PL and 6-4PP-PL were able to precisely detect the UV-induced DNA damage 
without interfering with NER activity (Figure 1B-D, Supplementary Figures S1A and B). 
Binding of repair proteins to DNA damage generally immobilizes them on chromatin, 
which can be quantified by fluorescence recovery after photo-bleaching (FRAP) [43, 
66]. Therefore, we performed FRAP experiments to quantitatively assess differences 
in the chromatin-bound fraction of PLs in response to different UV doses. FRAP of PLs 
showed that both CPD-PL and 6-4PP-PL are highly mobile in unperturbed cells (no UV) 
(Figure 2A and B), indicating that PLs are not stably bound to chromatin in the absence 
of DNA damage. Interestingly, both CPD-PL and 6-4PP-PL were immobilized in a dose-
dependent manner after UV irradiation (Figure 2A and B). From these FRAP curves, we 
determined the immobile fractions of the PLs (Supplementary Figure S2A and B), which 
revealed a linear increase for both CPD-PL and 6-4PP-PL with increasing UV doses up to 10 
J/m2. To assess whether the PL immobilization correlates with the actual quantity of CPDs 
and 6-4PPs, we quantified the relative amount of CPDs and 6-4PPs induced at these UV 
doses by immunofluorescence using photo lesion-specific antibodies [32] (Supplementary 
Figure S2C-E). Importantly, this revealed that the PL immobilization determined by PL 
FRAP (Figure 2C and D, primary Y-axis) at the indicated UV doses correlates very well with 
antibody-detected CPD and 6-4PP damage loads (Figure 2C and D, secondary Y-axis). This 
shows that FRAP of PLs allows a direct, relative quantification of UV-induced DNA damage 
in living cells. Interestingly, above 10 J/m2, hardly any increase in PL immobilization was 
observed. This is most likely caused by limiting amounts of non-bound PLs at higher UV 
doses, in line with the almost complete immobilization of PLs at 10J/m2 (Figure 2A and 
B). This may indicate that PL expression levels influence UV-induced PL immobilization. To 
test this, we compared the UV-induced PL immobilization in cells with low and high PL 
expression levels. This revealed that PL expression levels determine the dynamic range of 
PL mobility (Supplementary Figure S2F and G). Cells with low PL expression levels showed 
an increased immobilization at lower UV doses (e.g. 1 and 3 J/m2). However, this dose-
dependent increase in immobilization levelled off around 5J/m2. (Supplementary Figure 
S2F and G, left panels). In contrast, cells with high PL expression showed a reduced 
immobilization at low UV doses, but PL immobilization continued to increase at high 
damage loads (e.g. 10-20 J/m2) (Supplementary Figure S2F and G, right panels). These 
experiments demonstrate the importance of using cells with similar PL expression levels to 
avoid variation due to differences in the dynamic range of PL immobilization.
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Figure 2. mCherry-tagged PLs as quantitative and real-time damage markers in living cells. (A and 
B) UV dose-dependent immobilization of CPD-PL (A) and 6-4PP-PL (B). PL-expressing VH10 cells 
were non-irradiated or global UV-irradiated with the indicated UV doses and were directly analyzed 
by FRAP. The plotted values were normalized over the average pre-bleach signal (n=20 cells from 
2 independent experiments). (C and D) Immobile fractions of CPD-PL (C) and 6-4PP-PL (D) at 
the indicated UV-C doses were plotted together with the relative quantity of CPD and 6-4PP lesions 
at the same UV-C doses as determined by the mean fluorescence intensities in immunofluorescence 
assays using lesion-specific antibodies. 
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To test whether FRAP of PLs can also be used to study live-cell repair kinetics of CPDs 
and 6-4PPs, we UV irradiated cells and determined PL immobilization in time (Figure 3, 
Supplementary Figure S3A and B). In line with the previous experiments, both CPD-PL 
and 6-4PP-PL were strongly immobilized immediately upon UV exposure (10 J/m2). As 
expected, this immobilization decreased over time, reflecting the repair of CPD and 6-4PP 
lesions. While 6-4PP-PL was quickly mobilized, with a 50% reduction at 7h post UV and 
an almost complete mobilization at 24h post UV, the reduction in binding to damaged 
DNA by CPD-PL was much slower, in line with previously shown differences in repair 
rates of CPD and 6-4PP lesions [42, 44, 67]. The mobilization of PLs over time was almost 
completely blocked by siRNA-mediated depletion of the NER factor XPF (Figure 3 lower 
panel, Supplementary Figure S3A and B, lower panel and Supplementary Figure S3C), 
indicating that the mobilization of PLs in time represented repair of CPD and 6-4PP by 
NER. These results demonstrate that FRAP of PLs enables the real-time monitoring of DNA 
damage load in living cells and thus provides a sensitive method to detect perturbations 
of the NER reaction in living cells. 
Lesion-specific repair of UV-induced DNA damage in living cells
In addition to their use as quantitative live-cell damage markers, PLs can be used to 
specifically remove either CPD or 6-4PP lesions by direct reversal of the DNA damage 
using energy from near UV light (300–500 nm) [68, 69]. First, we determined optimal PR 
times for the repair of CPD and 6-4PP lesions (Figure 4A and B). PL-expressing cells were 
UV-irradiated and DNA damage was photo-reactivated with white light for the indicated 
times. While 5 min of PR was not enough for complete removal of DNA damages, 10 min 
PR resulted in a PL mobility similar to that of non-irradiated cells, indicative of an almost 
complete removal of DNA lesions (Figure 4A and B, Supplementary Figure S4A and B). 
Of note, the PL mobility was not affected in cells that were shielded from the white light 
during PR (UV + 10min mock).   
Having determined the optimal PR conditions, we assessed the previously described 
PR specificity of each PL. For this purpose, UV-induced DNA damage was photo-
reactivated and the CPD or 6-4PP lesions were detected using immunofluorescence with 
specific antibodies. As expected, we observed an almost complete loss of CPDs following 
PR in CPD-PL-expressing cells, while the quantity of 6-4PP lesions was not affected 
(Supplementary Figure S4C). In 6-4PP-PL-expressing cells, removal of only 6-4PP lesions, 
but not of CPD, was observed upon PR (Supplementary Figure S4C). 
After confirming that PL-expressing cells can specifically repair CPD or 6-4PP lesions, 
we made use of this feature to study live-cell DNA binding kinetics of XPC, the main 
damage sensor in GG-NER [4]. For this purpose, we co-expressed GFP-XPC and CPD-PL 
or 6-4PP-PL in HCT116 cells (Supplementary Figure S4D, left panel), and performed 
FRAP experiments to simultaneously asses the mobility of mCherry-tagged PLs and GFP-
tagged XPC (Figure 4C and D). As shown in the FRAP curves (Figure 4C and D) and 
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Figure 3. mCherry-tagged PLs to monitor DNA repair in living cells. (A) CPD-PL and (B) 6-4PP-PL 
expressing VH10 cells were transfected with the control (upper panel) or XPF siRNAs (siXPF) (lower 
panel). The plotted PL mobilities in non-irradiated or globally UV-C irradiated (10 J/m2) cells were 
determined by FRAP at the indicated time points post UV irradiation. (n ≥ 25 cells from 2 independent 
experiments for control siRNA experiment, n ≥ 15 for siXPF). 
the respective immobile fractions (Supplementary Figure S4E and F), UV irradiation led 
to the binding of GFP-XPC to damaged DNA resulting in its immobilization. Upon PR 
of each type of photo lesion, GFP-XPC immobilization was reduced, however not to 
the same extent as in non-irradiated cells. This is most likely due to the fact that XPC 
has affinity for both CPD and 6-4PP lesions [4, 70, 71]. PR of 6-4PPs and CPDs was 
successful as shown by the mobilization of both PLs upon PR (Supplementary Figure 
S4G and H). We observed more increase in the GFP-XPC mobilization upon PR of 6-4PPs 
compared to CPDs. Although XPC is able to directly recognize 6-4PP lesions, DDB2 
facilitates this recognition and is crucial for XPC to detect CPD lesions [5, 6, 72]. This 
suggests that the residual damage binding of XPC, following 6-4PP removal, represents 
DDB2-mediated binding to CPDs. To test this, we performed the same FRAP experiments 
in DDB2-deficient cells (Supplementary Figure S4D, right panel). In line with a stimulatory 
effect of DDB2 on XPC damage recognition, the UV-induced XPC immobilization was 
reduced by approximately 50% in DDB2 deficient cells (Figure 4E and F, Supplementary 
Figure S4E and F). Furthermore, in the absence of DDB2, GFP-XPC immobilization fully 
recovered after PR of 6-4PPs (Figure 4F and Supplementary Figure S4J), indicating that 
the UV-induced immobilization of XPC in DDB2-deficient cells is caused solely by 6-4PPs. 
In contrast, PR of CPDs (Supplementary Figure S4I) did not affect the XPC immobilization 
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Figure 4. Lesion-specific repair of UV-induced DNA damage in living cells. (A and B) Mobility of (A) 
CPD-PL and (B) 6-4PP-PL as determined by FRAP analysis. Cells were non-irradiated (no UV), globally 
UV-C irradiated with 10 J/m2 (UV), or globally UV-irradiated with 10 J/m2 and photo-reactivated (UV 
+ PR) for the indicated times by exposure to white light at 37oC. Cells were directly analyzed by FRAP 
after each treatment. ‘’UV + 10min mock’’ cells were UV-irradiated and mock photo-reactivated 
by shielding from white light during PR. (n ≥ 20 cells from 2 independent experiments) (C and D) 
GFP-XPC mobility was determined by FRAP in non-irradiated, globally UV-C irradiated (10 J/m2), or 
globally UV-C irradiated (10 J/m2) and photo-reactivated (10 min PR) in CPD-PL (C) or 6-4PP-PL (D) 
expressing cells. (E and F) Similarly, GFP-XPC mobility analysis was performed in DDB2 deficient cells 
(GFP-XPC DDB2-/-) (n ≥ 20 cells from 2 independent experiments).  
(Figure 4E), which confirms that XPC does not bind CPDs in DDB2-deficient cells. These 
experiments illustrate firstly, that the PL-mediated removal of specific UV-induced lesions 
can provide important quantitative insights into the behavior of NER factors on specific 
types of DNA lesions. Secondly, the direct comparison of PL and XPC mobility by FRAP 
in the same cell following the same UV exposure illustrated that fluorescently-labelled 
PLs can quantify DNA damage with a bigger dynamic range than XPC, as shown by 
the bigger immobile fraction of PLs (Supplementary Figure S4K). Thirdly, the mobility of 
PLs was not affected by the presence or absence of DDB2, which like PLs directly binds 
to DNA lesions [3] (compare Supplementary Figure S4G and I, and Supplementary Figure 
S4H and J). This shows that the dynamic range of PLs as live cell damage markers is not 
influenced by competitive substrate binding of PLs and DDB2. 
Local repair of UV-induced DNA damage in living cells
A limitation of the PR-based DNA damage removal described above is that full PR takes 
~10 minutes and needs to be performed before live-cell imaging. This interferes with 
the real-time measurement of the effects of DNA damage removal on proteins of interest 
in the cells. To improve our system, we set out to perform PR during live-cell imaging. As 
Potorous tridactylis CPD-PL and Arabidopsis thaliana 6-4PP-PL have absorption spectra 
that peak between 360 nm and 450 nm [65, 73], we tested whether it was possible to 
remove UV-induced damage by activating the PLs using a 405 nm laser during live cell 
imaging. CPD-PL-expressing cells were locally UV-irradiated resulting in accumulation of 
CPD-PL at sites of DNA damage (Figure 5A, upper panel). These locally accumulated 
CPD-PLs were subsequently exposed to different intensities of the 405 nm laser, which 
almost instantaneously released the damage-accumulated PLs already at 0.5 % 405 nm 
laser power (Figure 5A and B), reaching complete PR at 1 % laser power. To exclude that 
the loss of fluorescence at the damage site was caused by photo bleaching of mCherry, 
the 405 nm laser was also activated at a region outside the damage within the nucleus, 
which did not result in any reduction in signal intensity (Supplementary Figure S5A). 
To further confirm that PL exposure to the 405nm laser induced CPD removal by PR, 
we first photo-reactivated damaged DNA in a specific region (marked with the cross) 
in the nucleus and then stained the cells with a CPD specific antibody (Figure 5C). CPD 
lesions within the marked area were completely removed. In line with this, the mCherry 
signal of CPD-PL was reduced in the 405 nm laser-exposed region. This can be explained 
by its release and its subsequent binding to the areas in the nucleus where the damage 
is not removed. Additionally, 6-4PP lesions could also be removed upon PR by 6-4PP-PL, 
however, this required slightly higher 405 nm laser intensities (>5%) (Figure 5D and 4E, 
and Supplementary Figure S5B). 
Importantly, this live-cell PR is compatible with GFP imaging, as the PR-based repair is 
hardly triggered by the 488 nm laser at intensities that are commonly used for imaging 
GFP-tagged factors (Supplementary Figure S5C-H). Altogether, these results show that 
PLs can be used to photo reactivate UV-induced DNA damage in real-time in living cells, 
using the 405 nm laser. In conclusion, while the induction of DNA damage in living 
cells has been an available tool for many years [74] and resulted in many important 
mechanistic insights in the repair reaction, in this study, we introduce the repair of specific 
UV-induced DNA damage in living as a unique tool to study the dissociation of DNA repair 
factors and behavior of other cellular processes upon damage removal.
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Figure 5. Local repair of UV-induced DNA damage in living cells. (A) Representative images of 
CPD-PL-expressing VH10 cells before and 13 s after PR (pre-PR and post-PR, respectively) using 405 
nm laser at the indicated intensities. Arrows indicate local UV damage. Cells were locally UV-irradiated 
(60 J/m2), the local DNA damage spot and a region of the exact same size outside the damage within 
the nucleus were exposed after 7.8 s (indicated by arrow and PR) to the indicated intensities of 405 
nm laser for 13 s. Scale bar: 5 μm.(B) Relative mCherry fluorescence signal of CPD-PL was quantified 
inside and outside the DNA damage within the nucleus and normalized to pre-PR intensities at 
the local damage. (n = 8 cells, mean ± SEM) (C) Representative immunofluorescence images of 
CPD-PL-expressing VH10 cells after PR. Global UV-irradiation (10 J/m2) of the cells was followed by 
photo-reactivation of the damaged DNA by 5% 405 nm laser for 13 s in a specific region (region 
marked with dotted line) in the nucleus and the cells were subsequently fixed and stained with CPD 
antibody using immunofluorescence. (D) Representative images of locally UV-irradiated (60 J/m2) 
6-4PP-PL-expressing VH10 cells before and 13 s after PR (pre-PR and post-PR, respectively) using 
405 nm laser at the indicated intensities as described above in Figure 4A. Arrows are indicating 
the local UV-C damage spots. Scale bar: 5 μm. (E) Relative mCherry fluorescence signal of 6-4PP-PL 
was quantified inside and outside the DNA damage within the nucleus and normalized to pre-PR 
intensities at the local damage. (n = 8 cells, mean ± SEM) 
DISCUSSION
The currently available assays to investigate UV-induced DNA damage and repair have 
proven to be invaluable tools to study NER factors in both fundamental and clinical 
research. However, these assays cannot be performed in living cells, and are therefore 
confined to endpoint measurements instead of monitoring the DNA damage quantities 
in real time. Therefore, in this study, we developed a novel method using fluorescently-
tagged PLs to directly recognize and quantify UV-induced DNA damage in a highly 
sensitive manner in living cells. 
For this purpose, we made use of the high affinity of PLs for UV-induced DNA damage, 
which was confirmed by their accumulation at locally induced UV damage (Figure 1C and 
D), and their immobilization on damaged DNA during FRAP. Both CPD-PL and 6-4PP-PL 
showed a strong and reproducible UV dose-dependent immobilization. This approach 
allowed to quantitatively monitor the relative DNA damage loads (Figure 2A-D) and NER-
mediated repair kinetics in a highly sensitive manner (Figure 3). FRAP of PLs proved to 
be highly sensitive and enabled the detection of physiological relevant damage loads as 
low as 1 J/m2, which are difficult to quantify with other techniques. Furthermore, we 
observed a linear and relatively large dynamic range of PL immobilization between 0-10 
J/m2 UV, enabling precise quantification of the DNA damage loads. Of note, at higher 
UV doses (20 J/m2) the dose-dependent immobilization was not linear anymore, which 
might be caused by limiting amounts of non-chromatin bound PLs, in line with the almost 
complete immobilization of PLs at 10J/m2 (Figure 2A and B). 
In line with this, in cells with higher PL expression levels this levelling off of PL 
immobilization at higher UV doses was reduced, indicating that cells with higher PL levels 
are more suitable to quantify high damage loads (>5J/m2) (Supplementary Figure S2F and 
G, right graphs). On the other hand, our experiments show that cells with low PL expression 
levels allow a more sensitive detection of low damage loads (<5J/m2) (Supplementary 
Figure S2F and G, left graphs). Together these data show that the dynamic range of 
FRAP-based UV damage detection using fluorescently-tagged PLs can be adjusted to 
experimental needs by choosing cells with distinct PL expression levels. PL expression 
levels can easily be fine-tuned in the used lentiviral transduction system by the choice of 
promoter [64]. These data furthermore show the importance of using cells with similar 
PL expression levels when studying PL kinetics in different conditions. To achieve a very 
homogenous expression of fluorescently-tagged PLs, thereby potentially even increasing 
the precision of PL-mediated damage quantification, CRISPR/Cas9-mediated genomic 
targeting of PL expression cassettes to safe harbor loci like ROSA26 or AAVS1 [75] could 
be used. 
Furthermore, mutated PLs that are still capable of binding the UV-induced DNA 
damage, but are incapable of PR, might be developed, as these catalytically dead PLs 
will be insensitive to unintentional day light exposure during experimental handling. Of 
note, the FRAP-based PL assay is already very sensitive, as shown by the direct comparison 
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of the PL immobilization to that of XPC (Supplementary Figure S4K), the main damage 
sensor of GG-NER [4]. XPC is one of NER factors that shows the highest immobilization 
on UV-damaged DNA [42, 76, 77], however our FRAP data show that the fluorescently 
labeled PLs detect damage with even higher sensitivity than XPC. 
The precise correlation between PL immobilization and DNA damage load is most 
likely explained by the fact that exogenously expressed PLs, which function as single 
proteins, are most likely not regulated by the activity of other proteins, post-translational 
modifications or other forms of regulation in mammalian cells. Especially, these types 
of regulation have been shown to influence the direct correlation of the NER factor 
immobilization with the DNA damage quantity [17-19, 45, 47-49, 78]. The direct 
recognition of DNA damage with high affinity makes PLs ideally suited to visualize DNA 
damage in both living and fixed cells. Fluorescently-tagged PLs can therefore be used as 
sensitive, lesion-specific quantitative damage markers while studying the accumulation of 
other proteins at sites of local UV-induced damage [62, 74]. 
Of note, although the PLs have high affinity for DNA damage and are highly immobilized 
on damaged DNA, they did not interfere with NER. No differences were observed in the UV 
survival of parental and PL-expressing cells (Figure 1B). In line with this, PL expression 
did not block the accumulation of DDB2 on local UV damages (Figure 1C) or inhibit 
the NER-mediated repair, as shown by PL immobilization in time (Figure 3). The absence 
of interference with the NER reaction might be explained by a transient binding of the PLs 
to DNA damage, thereby allowing NER factors to access DNA lesions. In line with this, 
even though a large fraction of the PLs were immobilized following UV exposure, these 
PLs were not long-term immobilized on chromatin but were rather continuously released 
and rebound as evidenced by the continuous increase in the FRAP curves over time (Figure 
2A and B). Overall, our data showed that the use of fluorescently-labeled PLs is a robust 
and sensitive new method for the direct detection and quantification of UV-induced DNA 
damage in living cells. 
In addition to their use as sensitive DNA damage markers, the fluorescently-tagged 
PLs can also be used to revert the UV-induced damage by PR. In this case, the fluorescent 
tag could be used to monitor directly the DNA damage reversion by assessing PL 
immobilization. This feature allowed us to determine the minimally required PR times for 
CPD-PL and 6-4PP-PL (Figure 4A and B). Our results showed that 10-15 minutes of PR by 
exposure to white light was enough for both PLs to repair almost all of the lesions (Figure 
4A and B). This minimal PR duration is much shorter than the PR times of 1-4 h used in 
most previous studies performed in mammalian cells [6, 79-83]. The lesion-specific repair 
by CPD-PL and 6-4PP-PLs can be used to investigate the lesion-specific behavior of NER 
factors [6, 84]. These fluorescently-tagged PLs can be also used in combination with NER 
factors with different fluorescent tags, to simultaneously study the dynamic behavior of 
NER factor of interest while confirming the successful PR of CPD or 6-4PP lesions by PLs 
in the same FRAP experiment. As a proof of principle, we compared the GFP-XPC kinetics 
before and after PR, by simultaneously monitoring PR-mediated repair by PL mobility 
(Figure 4E and F). This approach could be applied to investigate the behavior of any 
fluorescently-tagged repair factor while monitoring the progress of either PR-based or 
endogenous repair over time in living cells. 
Despite the short required PR times, white light mediated-PR is technically incompatible 
with live cell imaging. To study cellular processes directly upon, or even during PR we 
developed PR using a 405 nm laser as a new method to repair DNA lesions during live-cell 
imaging. As the CPD-PL and 6-4PP-PL absorption spectra peak between 360 nm and 450 
nm, we photo-reactivates PLs using the 405 nm laser, which is commonly available in live 
cell imaging setups. Using laser pulses as short as 12.5 s, with relatively low laser power, 
allowed us to efficiently photo-reactivate DNA damage in live cell imaging experiments 
(Figure 5). Of note, while the 405 nm laser light can also be used to generate DNA 
damage, [85, 86], the laser intensity used for efficient PR is more than 10-fold lower 
than the intensities required to induce DNA damage [74]. Our results indicated that PR is 
rather specific for 405 nm laser, as PLs were not efficiently activated by the 488 nm laser 
at settings normally used for imaging GFP-tagged factors (Supplementary Figure S5C-H). 
Thus far, mainly association kinetics (Kon) of NER factors were studied using local DNA 
damage infliction during live cell imaging [74]. This has been a powerful tool to study 
the accumulation kinetics and recruitment order of fluorescently-tagged NER factors and 
has revealed crucial information about molecular mechanism and interdependencies of 
NER factors [41, 87]. Thus far the dissociation kinetics (Koff) of NER factors following 
DNA repair were more difficult to address, as the endogenous NER-mediated repair is 
expected to happen in a stochastic manner over time. Interestingly, our 405 nm laser-
assisted live-cell repair method enables to almost instantaneously remove DNA damage. 
This approach can be used to gain important insights into the release of NER factors, 
repair times and stability of NER intermediates. In addition, as the PLs are lesion-specific, 
these parameters could be specifically attributed to CPD or 6-4PP lesions. PR activity of 
the CPD and 6-4PP-PLs can also be used simultaneously to repair the vast majority of UV-
induced lesions directly. This allows testing whether specific cellular effects are caused by 
the DNA damage itself, or by other types of damages generated by UV exposure, such 
as membrane, protein, or RNA damage [88-90]. Additionally, 405 nm laser-mediated PR 
can be used to instantly repair sub-nuclear regions, which could be used to determine 
the contribution of DNA damage (in cis) or signaling pathways (in trans) to transcription 
inhibition, replication stress, or other cellular effects following UV damage [91-93].
In conclusion, here we describe how fluorescently-labeled PLs can be used as highly 
sensitive UV-induced DNA damage markers to quantitatively determine damage load and 
repair in real-time, in living cells. Moreover, the instant repair of DNA damage by activating 
PLs during live cell imaging opens new possibilities to assess the cellular effects following 
damage removal. In addition, lentiviral expression is highly efficient to stably express 
PLs in a broad range of cell lines. Overall, the methods described here are a valuable 
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extension of the current toolbox to study factors involved in the UV-induced DNA damage 
response, and will contribute to a better understanding of the molecular mechanism of 
NER in living cells. 
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Supplementary Figure 1. (A and B) The kinetics of endogenous DNA damage removal by NER 
was determined by quantifying the levels of 6-4PPs in time after 16 J/m2 (A) and CPDs in time after 
10 J/m2 (B) by immunofluorescence using 6-4PP and CPD specific antibodies. VH10 wild type cells 
(WT), VH10 cells expressing CPD-PL or 6-4PP-PL, and NER-compromised (XP-C) XP4PA cells were UV-
irradiated and allowed to repair for the indicated time points. Relative fluorescence directly after UV 
exposure was set at 100% and average fluorescence intensities were plotted in time (n>150 cells of 
2 independent experiments +/- SEM). (C) Representative immunofluorescence images of GFP-DDB2 
expressing VH10 cells that were transduced with either CPD-PL (upper panel) or 6-4PP-PL (lower 
panel). Cells were non-irradiated or locally UV-C irradiated (60 J/m2), directly fixed and stained with 
CPD or 6-4PP antibodies as indicated. Arrows indicate local UV damages. Scale bar: 7.5 μm.
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Supplementary Figure 2. (A and B) Immobile fractions of CPD-PL (A) and 6-4PP-PL (B) expressing 
VH10 cells in non-irradiated or globally UV-C irradiated at the indicated UV doses as determined 
by FRAP analyses shown in Figure 2A and 2B. Immobile fractions are calculated using the following 
formula: Immobile fraction (%) = 1 − ((average fluorescence intensity of UV-irradiated cells − 
the first post-bleach data point) / (average fluorescence intensity of non-irradiated cells−the first 
post-bleach data point)). The average fluorescence intensities are calculated over the measurements 
of the last 10 s. (n = 20 cells from 2 independent experiments, mean ± SEM). (C) Representative 
immunofluorescence images of non-irradiated (no UV) or globally UV-irradiated VH10 cells with 
the indicated UV doses, directly fixed and stained with CPD or 6-4PP antibodies as indicated. 
Scale bar: 25 μm. (D) CPD or (E) 6-4PP lesions (Supplementary Figure S3C) were quantified by 
determining the mean relative fluorescence intensities in immunofluorescence assays using lesion-
specific antibodies. (n ≥ 50 cells, mean ± SEM). UV-treated conditions were background corrected 
by subtracting the mean fluorescence intensity of the non-irradiated condition. (F and G) UV dose-
dependent immobilization of CPD-PL (F) and 6-4PP-PL (G) expressing VH10 cells with low (left panel) 
or high (right panel) PL expression levels. Non-irradiated or globally UV-irradiated cells were analyzed 
directly after irradiation with the indicated  UV doses. Relative fluorescence intensity (RFI) values 
were normalized to the average pre-bleach signal (n=20 cells from 2 independent experiments).
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Supplementary Figure S3
Supplementary Figure 3. (A and B) Immobile fractions of CPD-PL (A) and 6-4PP-PL (B) in VH10 cells, 
which were transfected with control (upper panel) or XPF (lower panel) siRNAs, were determined 
by FRAP analyses shown in Figure 3E and 3F. (n ≥ 15 cells from 2 independent experiments, mean ± 
SEM). (C) siRNA-mediated XPF knockdown was assessed by immunoblotting VH10 lysates with XPF 
antibody, tubulin staining was used as loading control. 
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Supplementary Figure 4. (A and B) Immobile fractions of non-irradiated, globally UV-irradiated 
(10 J/m2), or globally UV-irradiated (10 J/m2) and photo-reactivated CPD-PL (A) and 6-4PP-PL (B) as 
determined by the FRAP analyses depicted in Figure 3A and 3B. (C) Representative immunofluorescence 
images of CPD-PL or 6-4PP-PL-expressing VH10 cells using 6-4PP or CPD lesion specific antibodies as 
indicated. Cells were non-irradiated, globally UV-irradiated (10 J/m2), or globally UV-irradiated (10 J/
m2) and photo-reactivated (10 min PR), directly fixed and stained using immunofluorescence. Scale 
bar: 25 μm. (D) Upper panel; Expression of the full-length GFP-XPC protein and the concomitant 
loss of wild type (WT) XPC expression was confirmed by western blotting the lysates from WT and 
GFP-XPC knock-in HCT116 cell lines with an XPC antibody. Ku70 staining was used as loading 
control. * indicates an unspecific band. Lower Panel; CRISPR/Cas9-mediated DDB2 knock-out 
in GFP-XPC HCT116 cells was confirmed by western blotting with a DDB2 antibody.  (E and F) 
Immobile fractions of non-irradiated, globally UV-irradiated (10 J/m2), or globally UV-irradiated (10 
J/m2) and photo-reactivated (10 min) CPD-PL (E) and 6-4PP-PL (F) expressing GFP-XPC or GFP-XPC 
DDB2-/- (DDB2
-/-) HCT116 cells determined in the FRAP analyses depicted in Figure 3C-F. (G and 
H) FRAP analyses of PL-mCherry in non-irradiated, globally UV-irradiated (10 J/m2), or globally UV-
irradiated (10 J/m2) and photo-reactivated (10 min) CPD-PL (G) and 6-4PP-PL (H) expressing GFP-XPC 
HCT116 cells. (I and J) FRAP analyses of PL-mCherry in non-irradiated, globally UV-irradiated (10 
J/m2), or globally UV-irradiated (10 J/m2) and photo-reactivated (10 min) CPD-PL (I) and 6-4PP-PL 
(J) expressing GFP-XPC DDB2-/- HCT116 cells (n ≥ 20 cells from 2 independent experiments, mean 
± SEM). (K) Direct comparison of immobile fractions of CPD-PL, 6-4PP-PL and GFP-XPC in non-
irradiated or globally UV-irradiated (XX J/m2) cells (n ≥ 20 cells from 2 independent experiments, 
mean ± SEM). 
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Supplementary Figure 5. (A and B) Relative mCherry fluorescence signal of CPD-PL (A) and 
6-4PP-PL (B) in a non-damaged nuclear region following PR  normalized to pre-PR intensities at 
the local damage (n = 8 cells, mean ± SEM). Cells were locally UV-irradiated (60 J/m2), then a non-
damaged nuclear region was exposed after 7.5 sec (indicated by arrow and PR) to the indicated 
intensities of 405 nm laser for 13 s.  (n = 8 cells, mean ± SEM). (C and D) Representative images 
of CPD-PL (C) and 6-4PP-PL (D) expressing VH10 cells before and 13 s after PR using 488nm laser 
at the indicated intensity. Arrows indicate local UV damages. Scale bar: 5 μm. (E, F, G and H) Cells 
were locally UV-irradiated (60 J/m2), the local DNA damage spot and a region of the exact same 
size outside the damage within the nucleus were exposed after 7.5 s (indicated by arrow and PR) to 
the indicated intensities of 488 nm laser for 13 s. Relative fluorescence signal normalized to pre-PR 
intensities at the local damage of the mCherry-tagged PLs was quantified inside (E and F) and 
outside (G and H) the DNA damage within the nucleus. (n = 8 cells, mean ± SEM). 
Appendix &SUMMARY, SAMENVATTING, 
ZUSAMMENFASSUNG
CURRICULUM VITAE 
LIST OF PUBLICATIONS
PHD PORTFOLIO
ACKNOWLEDGEMENTS
APPENDIX
199
&
SUMMARY
The genetic information of all living organisms is stored in the nucleotide sequence of their 
DNA. Preserving the integrity of the DNA is a prerequisite for accurate gene expression 
and for faithful transmission of the genetic information to subsequent generations. 
DNA insults caused by endogenous metabolites or by environmental agents can damage 
DNA and can disrupt the essential cellular processes of gene transcription and DNA 
replication by blocking the forward translocation of the respective molecular machineries. 
If unrepaired, persistent DNA damage may eventually lead to malignant transformation 
or contribute to accelerated aging. To overcome these severe consequences, cells have 
evolved a DNA damage response network that consists of different dedicated DNA repair 
systems and damage-signaling pathways.
One of these repair pathways is Transcription-coupled Nucleotide excision repair 
(TC-NER), which specifically repairs DNA damage in the transcribed strand of active 
genes. TC-NER is initiated when RNA polymerase II (Pol II) is stalled during transcript 
elongation. DNA lesions that hinder or even fully block Pol II elongation are referred to 
as transcription-blocking DNA lesions (TBLs). The stalling of Pol II on TBLs triggers a series 
of highly regulated events, including Pol II processing to make the lesion accessible for 
DNA repair, R-loop-mediated DNA damage signaling, and the initiation of TC-NER. This 
multifaceted cellular response is reviewed in chapter 1. Furthermore, we discuss multiple 
aspects that thus far remained unclear in this field of research, including how cells 
coordinate transcription arrest, TBL repair and the subsequent restart of mRNA synthesis, 
and highlight research directions that may help answering these open questions.
In chapter 2 we describe how the development of GFP-RPB1 knock-in cells, intended 
as a new live-cell imaging tool to study the consequences of DNA damage-induced 
transcription stress on Pol II, led to the disclosure of a critical finding about the steady 
state kinetics of Pol II. By photo-bleaching of GFP-RPB1 we identified three kinetically 
distinct fractions of chromatin-bound Pol II and using dedicated small molecule inhibitors 
to arrest Pol II at defined stages of the transcription cycle we allocated them to free and 
initiating, promoter-paused, and elongating Pol II. Monte Carlo-based modeling of Pol II 
kinetics allowed assessing a quantitative framework of the Pol II transcription cycle. This 
revealed that on average 7% of all Pol II complexes are freely diffusing, while 10% are 
chromatin-bound for 2.4 s during initiation, and 23% are promoter-paused for only 42 s. 
This unexpectedly high turnover of Pol II at promoters is most likely caused by premature 
termination of initiating and promoter-paused Pol II, and is in sharp contrast to the 23 min 
that elongating Pol II resides on chromatin. Our findings are highly supportive of a model 
in which Pol II initiation and promoter pausing are highly dynamic events of iterative 
cycles of Pol II chromatin binding and release. As a consequence of the frequent abortive 
release after initiation and pausing only one mRNA transcript will be synthesized per 100 
Pol II initiation events, highlighting the importance of initiation and promoter pausing as 
key regulatory control events. In conclusion our study suggests that the iterative release 
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and re-initiation of promoter-bound Pol II is an important component of transcriptional 
regulation and supported by multiple independent studies, we suggest that this dynamic 
behavior creates an integrative hub that permits the rapid adaptation of transcription to 
various stimuli. 
The work presented in chapter 3 corroborates this notion, by revealing that the UV-
induced regulation of promoter-paused Pol II is an important, newly identified 
component of the cellular response to transcription stress. We show that UV-induced 
damage not only immediately inhibits Pol II elongation in a dose-dependent manner, 
but importantly, also leads to the proteasomal degradation of promoter-bound Pol II. 
This degradation is preceded by the genome-wide extraction of promoter-paused Pol 
II by the ubiquitin-dependent VCP/p97 segregase. Furthermore, we demonstrate 
that this UV-induced degradation of promoter-paused Pol II is regulated in trans and is 
mechanistically distinct from the processing of lesion-stalled Pol II. Strikingly, this trans 
regulatory transcription control does not depend on functional transcription-coupled 
nucleotide excision repair. In line with several recent studies, this establishes the 
regulation of non-lesion-stalled Pol II as a new component of the cellular response to 
transcription stress.
In chapter 4 we describe the identification of several new factors and 
processes involved in the regulation of cell survival following UV irradiation using 
a genome-wide lentiviral CRISPR/Cas9-mediated loss of function screen. We 
screened for genes that upon knockout (KO) resulted in a significant survival 
advantage (positive selection) or disadvantage (negative selection) after repeated 
induction of TBLs. Furthermore, we determined the dependency of the identified 
factors on TC-NER or on GG-NER, by screening in addition to NER-proficient wild 
type cells, isogenic CSB KO, and XPC KO cells, respectively. We identified 156 genes 
(49 negative, 107 positive) in WT cells, 149 genes (33 negative, 116 positive) in CSB 
KO cells, and 79 genes (21 negative, 58 positive) in XPC KO cells that might be involved 
in regulating cellular survival after UV irradiation. Importantly, established key factors 
of the NER pathway were amongst the top hits of genes in WT cells that decreased 
UV survival upon knockout, demonstrating the validity of the screen. STRING protein 
network and gene ontology term enrichment analysis confirmed the importance of 
several identified protein networks, such as translesion DNA synthesis and the 
COP9 signalosome to be crucial for cellular survival after UV, corroborating the 
potential of the newly identified genes to play bona fide roles in the UV-DDR. 
In chapter 5 we demonstrate how UV-lesion-specific photolyases can be used 
to locate, quantify and instantaneously repair UV-induced photo-lesions in living 
cells, providing a highly sensitive new tool to study the UV-induced DNA damage 
response in real time in living cells.
Finally, in chapter 6, the main conclusions derived from the data presented 
in this thesis are summarized, and their implications and contributions to our 
understanding of DNA-damage induced cellular response to transcription stress are 
emphasized. 
SAMENVATTING
De genetische informatie van alle levende organismen wordt opgeslagen in 
de nucleotidesequentie van hun DNA. Het behouden van de integriteit van het DNA 
is een voorwaarde voor correcte genexpressie en voor een goede overdracht van 
de genetische informatie naar volgende generaties. DNA-beschadigingen veroorzaakt 
door endogene metabolieten of omgevingsfactoren kunnen de essentiële cellulaire 
processen van gentranscriptie en DNA-replicatie verstoren door de progressie van deze 
moleculaire mechanismes te blokkeren. Indien niet hersteld, kan langaanhoudende DNA-
schade uiteindelijk leiden tot kwaadaardige transformatie of bijdragen aan versnelde 
veroudering. Om deze ernstige gevolgen te voorkomen, hebben cellen een DNA-schade 
reactienetwerk ontwikkeld dat bestaat uit verschillende specifieke DNA-reparatiesystemen 
en schadesignaleringsroutes.
Een van deze reparatieroutes is transcriptie-gekoppeld nucleotide excisie herstel 
(TC-NER), wat specifiek DNA-schade in de getranscribeerde streng van actieve genen 
herstelt. TC-NER wordt geïnitieerd wanneer RNA polymerase II (Pol II) vastloopt tijdens 
transcriptie elongatie. DNA-laesies die Pol II elongatie belemmeren of zelfs volledig 
blokkeren, worden transcriptie-blokkerende DNA-laesies (TBL’s) genoemd. Het vastlopen 
van Pol II op TBL’s start een reeks sterk gereguleerde gebeurtenissen, waaronder het 
verwerken van Pol II om de laesie toegankelijk te maken voor DNA-reparatie, R-loop-
gemedieerde DNA-schadesignalering en het starten van TC-NER. Deze veelzijdige, 
cellulaire respons wordt besproken in hoofdstuk 1. Verder bespreken we meerdere 
aspecten die tot nu toe onduidelijk bleven in dit onderzoeksveld, waaronder hoe cellen 
het vastlopen van transcriptie coördineren, TBL reparatie en de daaropvolgende herstart 
van de mRNA synthese, en belichten we onderzoeksrichtingen die mogelijk helpen bij het 
beantwoorden van deze open vragen.
In hoofdstuk 2 beschrijven we hoe de ontwikkeling van GFP-RPB1 knock-in cellen, 
bedoeld als nieuw hulpmiddel voor het bestuderen van de gevolgen van door DNA-schade 
geïnduceerde transcriptie stress op Pol II in levende cellen, leidde tot de onthulling van 
een belangrijke bevinding over de steady-state kinetiek van Pol II. Door middel van het 
fotobleken van GFP-RPB1 hebben we drie kinetisch verschillende fracties van chromatine-
gebonden Pol II geïdentificeerd en met behulp van specifieke klein molecuulremmers, 
die Pol II in verschillende stadia van de transcriptiecyclus houden, hebben we de fracties 
ingedeeld als vrij en initiërend, promotor-gepauzeerd en elongerend Pol II. Het bekijken 
van de Pol II kinetiek met een op Monte Carlo modellering gebaseerd model gaf een 
kwantitatieve basis voor het beoordelen van de transcriptie cyclus. Hieruit bleek dat 
gemiddeld 7% van alle Pol II complexen vrij diffundeert, terwijl 10% chromatine-
gebonden is gedurende 2,4 seconden tijdens de initiatie en 23% pauzeert op de promotor 
gedurende slechts 42 seconden. Deze onverwacht hoge omzet van Pol II op promotors 
wordt hoogstwaarschijnlijk veroorzaakt door voortijdige beëindiging van initiërend en 
promotor-gepauzeerd Pol II, en staat in schril contrast met de 23 minuten dat elongerend 
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Pol II op chromatine aanwezig is. Onze bevindingen ondersteunen een model waarin Pol II 
initiatie en promotor-pauzering zeer dynamische gebeurtenissen zijn van opeenvolgende 
cycli van het binden en loslaten van chromatine door Pol II. Als gevolg van het frequente 
afbreken van transcriptie en het loslaten van Pol II na initiatie en pauzering, zal slechts 
één mRNA-transcript worden gesynthetiseerd per 100 Pol II initiatie gebeurtenissen, wat 
het belang van initiatie en promotor-pauzering als regulerend controlepunt benadrukt. 
In conclusie suggereert onze studie dat de opeenvolgende loslating en nieuwe binding 
van promotor-gebonden Pol II een belangrijk onderdeel is van de transcriptie regulatie en, 
ondersteund door meerdere onafhankelijke studies, suggereren we dat dit dynamische 
gedrag een centrum creëert die de snelle aanpassing van transcriptie mogelijk maakt op  
verschillende stimuli.
Het werk dat wordt gepresenteerd in hoofdstuk 3 bevestigt dit idee door de 
onthulling dat de regulatie van UV-geïnduceerd promotor-gepauzeerd Pol II een 
belangrijk nieuw onderdeel is van de cellulaire reactie op transcriptie stress. We 
laten zien dat UV-geïnduceerde schade niet alleen direct de Pol II elongatie remt in 
een dosisafhankelijke manier maar, nog belangrijker, dat dit ook leidt tot proteosomale 
afbraak van promotor-gebonden Pol II. Deze afbraak wordt voorafgegaan door het 
losmaken van promotor-gepauzeerd Pol II van het gehele genoom door het 
ubiquitine-afhankelijke VCP/p97 segregase. Verder laten we zien dat deze UV-
geïnduceerde afbraak van promotor-gebonden Pol II in trans wordt gereguleerd en 
dat dit mechanistisch anders is dan het verwerken van laesie-gebonden Pol II. 
Opvallend genoeg is transcriptie regulatie in trans onafhankelijk van functioneel 
transcriptie-gekoppeld nucleotide excisie herstel. In overeenstemming met 
verschillende recente studies laat dit zien dat de regulatie van niet-laesie-gebonden 
Pol II een nieuw onderdeel is van de cellulaire reactie op  transcriptie stress. 
In hoofdstuk 4 beschrijven we de identificatie van verschillende nieuwe factoren en 
processen die betrokken zijn bij het reguleren van cellulaire overleving na UV-
bestraling, gevonden met behulp van een genoombrede lentivirale CRISPR/Cas9-
gemedieerde verlies-van-functie screen. We zochten genen die na het maken van een 
knock-out (KO) een significant betere (positieve selectie) of slechtere (negatieve 
selectie) overleving hadden na het herhaaldelijk induceren van TBL’s. Verder hebben 
we de afhankelijkheid van de geïdentificeerde factoren op TC-NER of GG-NER bepaald, 
door gebruik te maken van isogene CSB KO en XPC KO cellen in toevoeging op 
de wildtype cellen met functioneel NER. We hebben 156 genen (49 negatief, 107 
positief) geïdentificeerd in WT cellen, 149 genen (33 negatief, 116 positief) in CSB 
KO cellen en 79 genen (21 negatief, 58 positief) in XPC KO cellen, die mogelijk 
betrokken zijn bij het reguleren van cellulaire overleving na UV-bestraling. Belangrijk 
is dat bekende essentiële factoren van de NER-mechanismes tot de tophits van genen 
in WT cellen behoorden die de UV-overleving bij knock-out verminderden, wat de 
functionaliteit van de screen aantoonde. STRING-eiwitnetwerkanalyse en gen-
ontologie term verrijkinganalyse bevestigden dat verschillende van de 
geïdentificeerde eiwitnetwerken belangrijk zijn voor cellulaire 
overleving na UV, zoals translesie DNA-synthese en het COP9 signalosoom, daarmee 
wordt het potentieel van nieuw geïdentificeerde genen bevestigt om een bonafide 
rol te spelen in de UV-DDR.
In hoofdstuk 5 laten we zien hoe een UV-laesie specifieke f otolyase gebruikt k an 
worden voor het lokaliseren, kwantificeren en direct repareren van een UV-geïnduceerde 
fotolaesie in levende cellen, dit geeft een erg gevoelig, nieuw mechanisme voor het 
bestuderen van de UV-geïnduceerde DNA-schade reactie in levende cellen in tijd. 
Tot slot, in hoofdstuk 6, worden de belangrijkste conclusies samengevat die worden 
getrokken uit de data in dit proefschrift, en worden de implicaties en toevoegingen 
aan ons begrip van de DNA-schade geïnduceerde cellulaire reactie op transcriptie  
stress benadrukt.
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DEUTSCHE ZUSAMMENFASSUNG
Die genetische Information aller lebenden Organismen ist in der Nukleotidsequenz ihrer 
DNA gespeichert. Die Erhaltung der Integrität der DNA ist eine Voraussetzung für eine 
genaue Genexpression und für eine getreue Übertragung der genetischen Informationen 
an nachfolgende Generationen. Umwelteinflüsse oder endogene Metaboliten können 
die DNA schädigen und die wesentlichen zellulären Prozesse der Gentranskription sowie 
DNA-Replikation stören, indem sie die Vorwärtsverlagerung der jeweiligen molekularen 
Maschinen blockieren. Wenn solche DNA-Schäden nicht repariert werden, können sie 
zu bösartigen Zellveränderungen führen oder den Alterungsprozess beschleunigen. Um 
diese schwerwiegenden Folgen zu überwinden, haben Zellen ein DNA-Schadensantwort-
Netzwerk entwickelt, welches aus verschiedenen speziellen DNA-Reparatursystemen und 
Schadenssignalwegen besteht.
Eines dieser Reparatursysteme ist die Transkriptionsgekoppelte Nucleotid Excision 
Repair (TC-NER), die speziell DNA-Schäden im transkribierten Strang aktiver Gene 
repariert. TC-NER wird eingeleitet, wenn die RNA-Polymerase II (Pol II) während der 
Transkription blockiert wird. DNA-Schäden, die die Pol-II-Transkription behindern oder 
sogar vollständig blockieren, werden als transkriptionsblockierende DNA-Läsionen (TBLs) 
bezeichnet. Der Stillstand von Pol II auf TBLs löst eine Reihe von stark regulierten Ereignissen 
aus, darunter die Pol II-Verarbeitung um die Läsion für die DNA-Reparatur zugänglich zu 
machen, die R-Schleifen-vermittelte DNA-Schadenssignalisierung und die Einleitung von 
TC-NER. Diese vielschichtige zelluläre Reaktion wird in Kapitel 1 behandelt. Darüber 
hinaus diskutieren wir mehrere Aspekte, die in diesem Forschungsgebiet bisher unklar 
geblieben sind, darunter die Frage, wie Zellen den Transkriptionsstillstand, die TBL-
Reparatur und den anschließenden Neustart der mRNA-Synthese koordinieren, und 
zeigen Forschungsrichtungen auf, die bei der Beantwortung dieser offenen Fragen 
helfen können.
In Kapitel 2 beschreiben wir wie GFP-RPB1-Knock-In-Zellen, die als neues „live-
cell-Imaging“ Tool zur Untersuchung der Folgen von DNA-Schaden-induziertem 
Transkriptionsstress auf Pol II entwickelt wurden, zu neuen Erkenntnissen über 
die stationäre Kinetik von Pol II führten. Durch die „Fotobleichung“-Technik von GFP-RPB1 
identifizierten wir drei kinetisch unterschiedliche Fraktionen von chromatingebundenen 
Pol II. Zusätzlich dazu hielten wir Pol II mithilfe von speziellen „small-molecule“ 
Inhibitoren in definierten Phasen des Transkriptionszyklus an, und konnten sie somit 
dem freien und initiierenden, promotorpausenden und verlängerten Pol II zuordnen. 
Die Monte-Carlo-basierte Modellierung der Pol-II-Kinetik ermöglichte die Bewertung 
eines quantitativen Rahmens des Pol-II-Transkriptionszyklus. Dabei stellte sich heraus, 
dass durchschnittlich 7% aller Pol-II-Komplexe frei diffundierend sind, während 10% 
während der Initiierung für 2,4 Sekunden lang chromatingebunden sind und 23% 
nur 42 Sekunden lang promotorpausiert sind. Dieser unerwartet hohe Umsatz von 
Pol II bei Promotoren wird höchstwahrscheinlich durch die vorzeitige Beendigung der 
Initiierung und der promotorpausierten Pol II verursacht, und steht in scharfem Kontrast 
zu den 23 Minuten, in denen sich das verlängerte Pol II auf Chromatin befindet. Unsere 
Ergebnisse unterstützen ein Modell, bei dem die Pol-II-Initiation und die Promotorpause 
hochdynamische Ereignisse iterativer Zyklen der Pol-II-Chromatinbindung und -freigabe 
sind. Als Folge des häufigen A bbruchs n ach d er I nitiierung u nd P ause, w ird n ur e in 
mRNA-Transkript pro 100 Pol II-Initiationsereignisse synthetisiert, was die Bedeutung von 
Initiierung und Promotorpause als wichtige regulatorische Kontrollereignisse deutlich 
unterstreicht. Abschließend schlägt unsere Studie vor, dass die iterative Freisetzung 
und Reinitiierung von Promoter-gebundenem Pol II ist ein wichtiger Bestandteil der 
transkriptionellen Regulierung ist und, durch mehrere unabhängige Studien unterstützt, 
schlagen wir vor dass dieses dynamische Verhalten eine integrative Drehscheibe schafft, 
die die rasche Anpassung der Transkription an verschiedene Reize ermöglicht. 
Die in Kapitel 3 vorgestellte Studie bestätigt diese These, indem sie aufzeigt, 
dass die UV-induzierte Regulation von Promotor-pausiertem Pol II eine wichtige, 
neu identifizierte Komponente der zellulären Reaktion auf Transkriptionsstress ist. 
Wir zeigen, dass UV-induzierte Schäden nicht nur die Pol-II-Elongation dosisabhängig 
sofort hemmen, sondern vor allem auch zum proteasomalen Abbau von 
promotorgebundenem Pol II führen. Diesem Abbau geht die genomweite Extraktion 
von Promotor-pausiertem Pol II durch die Ubiquitin-abhängige VCP/p97-Segregase 
voraus. Darüber hinaus zeigen wir, dass dieser UV-induzierte Abbau von Promotor-
pausierten Pol II in trans reguliert wird und sich mechanistisch von der Verarbeitung von 
Läsions-pausierten Pol II unterscheidet. Auffallend ist, dass diese 
Transkriptionskontrolle in trans nicht von der Reparatur des Schadens durch TC-NER 
abhängt. In Übereinstimmung mit mehreren neuen Studien, wird damit die 
Regulierung von nicht Läsions-pausierten Pol II als neuer Bestandteil der zellulären 
Reaktion auf Transkriptionsstress etabliert.
In Kapitel 4 beschreiben wir die Identifizierung mehrerer neuer Faktoren 
und Prozesse, die an der Regulierung des Zellüberlebens nach UV-Bestrahlung 
beteiligt sind mit einem genomweiten lentiviralen CRISPR/Cas9-vermittelten 
Funktionsverlust-Screen. Wir haben nach Genen gesucht, die bei Knockout (KO) 
nach wiederholter Induktion von TBLs zu einem signifikanten Überlebensvorteil 
(positive Selektion) oder Nachteil (negative Selektion) geführt haben. Darüber 
hinaus haben wir die Abhängigkeit der identifizierten Faktoren von TC-NER oder 
GG-NER bestimmt, indem wir zusätzlich zu NER-profizienten Wildtypzellen, isogenen 
CSB KO- und XPC KO-Zellen gescreent haben. Wir identifizierten 156 Gene (49 negativ, 
107 positiv) in WT-Zellen, 149 Gene (33 negativ, 116 positiv) in CSB-KO-Zellen und 79 
Gene (21 negativ, 58 positiv) in XPC-KO-Zellen, die an der Regulierung des 
Zellüberlebens nach UV-Bestrahlung beteiligt sein könnten. Wichtig ist, dass die 
etablierten Schlüsselfaktoren des NER-Weges zu den Top-Treffern der Gene in WT-
Zellen gehörten, die das UV-Überleben beim Knockout verkürzten und die Gültigkeit 
der Screening-Methode bestätigten. STRING Protein-Netzwerk und Gen-Ontologie-
Term-Anreicherungsanalysen bestätigten die Relevanz mehrerer identifizierter 
Proteinnetzwerke, wie z.B. der Translations-DNA-Synthese und des COP9-Signalosoms, 
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die für das zelluläre Überleben nach UV-Bestrahlung entscheidend sind, und 
bestätigten das Potenzial der neu identifizierten Gene, bedeutende Rollen in der UV-
DDR zu spielen. 
In Kapitel 5 zeigen wir, wie UV-läsionsspezifische Photolyasen verwendet 
werden können, um UV-induzierte Photoläsionen in lebenden Zellen zu 
lokalisieren, zu quantifizieren und sofort zu reparieren. Damit stellen wir ein 
hochempfindliches neues Werkzeug zur Verfügung, um die UV-induzierte DNA-
Schadenreaktion in Echtzeit in lebenden Zellen zu untersuchen. 
Abschließend werden in Kapitel 6 die wichtigsten Schlussfolgerungen aus 
den Daten, die in dieser Arbeit zusammengefasst sind, sowie ihre Auswirkungen 
und Beiträge zu unserem Verständnis von DNA-Schäden induzierte zelluläre 
Reaktionen auf Transkriptionsstress erläutert und betont.
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